JP2017088879A - Method for producing aminobenzopyranoxanthene (abpx) dye compound - Google Patents

Method for producing aminobenzopyranoxanthene (abpx) dye compound Download PDF

Info

Publication number
JP2017088879A
JP2017088879A JP2016216617A JP2016216617A JP2017088879A JP 2017088879 A JP2017088879 A JP 2017088879A JP 2016216617 A JP2016216617 A JP 2016216617A JP 2016216617 A JP2016216617 A JP 2016216617A JP 2017088879 A JP2017088879 A JP 2017088879A
Authority
JP
Japan
Prior art keywords
group
compound
bonded
general formula
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016216617A
Other languages
Japanese (ja)
Other versions
JP6869524B2 (en
Inventor
伸一郎 神野
Shinichiro Kamino
伸一郎 神野
澤田 大介
Daisuke Sawada
大介 澤田
秀一 榎本
Shuichi Enomoto
秀一 榎本
恭良 渡辺
Yasuyoshi Watanabe
恭良 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Publication of JP2017088879A publication Critical patent/JP2017088879A/en
Application granted granted Critical
Publication of JP6869524B2 publication Critical patent/JP6869524B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing an aminobenzopyranoxanthene (ABPX) dye compound in a high yield.SOLUTION: The method for producing an ABPX compound represented by formula (3) comprises reacting a compound represented by formula (1) with a compound represented by formula (2) in the presence of a condensing agent. [Each Ris independently H, a 1-6C alkyl group, or the like; Rand Rare each independently H, an alkyl group, or the like, provided that at least one of Rand Ris an alkyl group or the like; Rand Rare each independently a halogen atom, a 1-6C alkyl group, or a carboxyl group; m is an integer of 0-3; and n is an integer of 0-4.]SELECTED DRAWING: None

Description

本発明は、アミノベンゾピラノキサンテン系(ABPX)色素化合物の製造方法に関する。   The present invention relates to a method for producing an aminobenzopyranoxanthene-based (ABPX) dye compound.

ローダミン2分子が縮合したアミノベンゾピラノキサンテン系(ABPX)色素化合物は、一分子多色性を示す有機色素化合物であり、その光物性の特徴を利用して、センシング材料等として広く応用されている(特許文献1及び非特許文献1、2)。   Aminobenzopyranoxanthene-based (ABPX) dye compounds condensed with two rhodamine molecules are organic dye compounds that exhibit single-molecule polychromaticity, and are widely applied as sensing materials by utilizing their optical properties. (Patent Document 1 and Non-Patent Documents 1 and 2).

アミノベンゾピラノキサンテン系(ABPX)色素化合物において、キサンテン環構造の窒素部位を縮環した誘導体は発光効率が高くなることや、吸収波長や蛍光波長が変化することが知られているが、ベンゾフェノン誘導体とレゾルシノールとの溶融加熱反応を用いた従来の合成法では、ロドール(Rhodol)をはじめとする副生成物の生成により、反応収率の低下をもたらすといった課題があり実用性に乏しかった(非特許文献3)。   In aminobenzopyranoxanthene-based (ABPX) dye compounds, it is known that derivatives fused to the nitrogen moiety of the xanthene ring structure have higher luminous efficiency and change in absorption wavelength and fluorescence wavelength. In the conventional synthesis method using a melt-heat reaction between a derivative and resorcinol, the production of by-products such as rhodol (Rhodol) has a problem in that the reaction yield is reduced, which is not practical (non-practical). Patent Document 3).

米国特許第8134017号明細書U.S. Pat. No. 8,134,017

Y. Shirasaki et al., "New Aminobenzopyranoxanthene-Based Colorimetric Sensor for Copper (II) Ions with Dual-Color Signal Detection System", Chem. Asian. J, 2013年, 8, p.2609-2613Y. Shirasaki et al., "New Aminobenzopyranoxanthene-Based Colorimetric Sensor for Copper (II) Ions with Dual-Color Signal Detection System", Chem. Asian. J, 2013, 8, p.2609-2613 M. Tanioka et al., "Reversible Near-Infrared/Blue Mechanofluorochromism of Aminobenzopyranoxanthene", J. Am. Chem. Soc., 2015年, 137, p.6436-6439M. Tanioka et al., "Reversible Near-Infrared / Blue Mechanofluorochromism of Aminobenzopyranoxanthene", J. Am. Chem. Soc., 2015, 137, p.6436-6439 S. Kamino et al., "Design and Syntheses of Highly Emissive Aminobenzopyrano-xanthene Dyes in the Visible and Far-Red Regions", Org. Lett., 2014年, 16, p.258-261S. Kamino et al., "Design and Syntheses of Highly Emissive Aminobenzopyrano-xanthene Dyes in the Visible and Far-Red Regions", Org. Lett., 2014, 16, p.258-261

従って、本発明は、高収率でアミノベンゾピラノキサンテン系(ABPX)色素化合物を得ることができる製造方法を提供することを目的とする。
また、本発明は、従来合成できなかった、キサンテン環構造の2つの窒素原子が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物並びに、2つのフェニル環構造が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物の製造方法を提供することを目的とする。
Therefore, an object of the present invention is to provide a production method capable of obtaining an aminobenzopyranoxanthene-based (ABPX) dye compound with high yield.
The present invention also provides an aminobenzopyranoxanthene-based (ABPX) dye compound in which two nitrogen atoms of a xanthene ring structure have an asymmetric substituent, and a substituent in which two phenyl ring structures are asymmetric, which could not be synthesized conventionally. It is an object of the present invention to provide a method for producing an aminobenzopyranoxanthene-based (ABPX) dye compound having the following.

本願発明者らは、上記課題を解決するために鋭意研究を行った結果、以下の製造方法が上述した課題を解決できることを見出し、本発明に想到するに至った。   As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that the following manufacturing method can solve the above-described problems, and have come to the present invention.

即ち、本発明は、次の発明を提供するものである。   That is, the present invention provides the following inventions.

<1>
下記一般式(1)で表される化合物と下記一般式(2)で表される化合物とを縮合剤の存在下反応させることを特徴とする、下記一般式(3)で表される化合物の製造方法。
<1>
A compound represented by the following general formula (3), characterized in that a compound represented by the following general formula (1) and a compound represented by the following general formula (2) are reacted in the presence of a condensing agent. Production method.

Figure 2017088879
Figure 2017088879

[一般式(1)〜(3)中、R1は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1が結合して環を形成してもよく、又はR1が結合している窒素原子と共にヘテロ環を形成していてもよい。R2及びR4は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。] [In General Formulas (1) to (3), each R 1 independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms, or two R 1 bonded to each other. May form a ring, or may form a heterocycle together with the nitrogen atom to which R 1 is bonded. R 2 and R 4 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but a plurality of R 3 may be bonded to form a ring. R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. ]

<2>
一般式(1)で表される化合物と一般式(2)で表される化合物とを縮合剤の存在下反応させ一般式(4)で表される化合物を得、
次に、前記一般式(4)で表される化合物と一般式(5)で表される化合物とを縮合剤の存在下反応させ一般式(6)で表される化合物を得、
さらに、前記一般式(6)で表される化合物を環化することを特徴とする、一般式(7)で表される化合物の製造方法。
<2>
The compound represented by general formula (1) and the compound represented by general formula (2) are reacted in the presence of a condensing agent to obtain a compound represented by general formula (4),
Next, the compound represented by the general formula (4) and the compound represented by the general formula (5) are reacted in the presence of a condensing agent to obtain a compound represented by the general formula (6).
Furthermore, the compound represented by the general formula (6) is cyclized. A method for producing the compound represented by the general formula (7).

Figure 2017088879
Figure 2017088879

[一般式(1)〜(2)及び(4)〜(7)中、R1及びR5は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1同士もしくは2つのR5同士が結合して環を形成してもよく、又はR1もしくはR5が結合している窒素原子と共にヘテロ環を形成していてもよい。R2、R4及びR6は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3及びR7は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3同士又は複数のR7同士が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。R9は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R5とR9が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。oは0〜3の数を示す。pは0〜4の数を示す。] [In General Formulas (1) to (2) and (4) to (7), R 1 and R 5 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms. Or two R 1 s or two R 5 s may be bonded to form a ring, or a heterocycle may be formed together with the nitrogen atom to which R 1 or R 5 is bonded. . R 2 , R 4 and R 6 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 and R 7 are each independently a halogen atom or an alkyl group or a carboxyl group having 1 to 6 carbon atoms, may form a ring plurality of R 3 s or more R 7 are bonded to each other . R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. R 9 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but R 5 and R 9 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. o shows the number of 0-3. p shows the number of 0-4. ]

<3>
一般式(7)で表される化合物。
<3>
The compound represented by General formula (7).

Figure 2017088879
Figure 2017088879

[一般式(7)中、R1及びR5は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1同士もしくは2つのR5同士が結合して環を形成してもよく、又はR1もしくはR5が結合している窒素原子と共にヘテロ環を形成していてもよい。R3及びR7は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3同士又は複数のR7同士が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。R9は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R5とR9が結合して環を形成してもよい。但し、R1及びR5、R3及びR7並びにR8及びR9のうち少なくとも一組は、互いに異なるものを示す。mは0〜3の数を示す。nは0〜4の数を示す。oは0〜3の数を示す。pは0〜4の数を示す。] [In the general formula (7), R 1 and R 5 each independently represent a hydrogen atom, or an alkyl group or an aryl group having 6 to 14 carbon atoms having 1 to 6 carbon atoms, the two R 1 together or two R 5 may be bonded to each other to form a ring, or a heterocycle may be formed together with the nitrogen atom to which R 1 or R 5 is bonded. R 3 and R 7 are each independently a halogen atom or an alkyl group or a carboxyl group having 1 to 6 carbon atoms, may form a ring plurality of R 3 s or more R 7 are bonded to each other . R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. R 9 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but R 5 and R 9 may be bonded to form a ring. However, at least one of R 1 and R 5 , R 3 and R 7 and R 8 and R 9 is different from each other. m shows the number of 0-3. n shows the number of 0-4. o shows the number of 0-3. p shows the number of 0-4. ]

<4>
一般式(4)で表される化合物。
<4>
The compound represented by General formula (4).

Figure 2017088879
Figure 2017088879

[一般式(4)中、R1は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1が結合して環を形成してもよく、又はR1が結合している窒素原子と共にヘテロ環を形成していてもよい。R2及びR4は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3は、ハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。] [In General Formula (4), each R 1 independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms, or two R 1 's bonded to form a ring. Or may form a heterocycle together with the nitrogen atom to which R 1 is bonded. R 2 and R 4 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but a plurality of R 3 may be bonded to form a ring. R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. ]

本発明によれば、高収率でアミノベンゾピラノキサンテン系(ABPX)色素化合物を得ることができる。さらに、本発明の製造方法によれば、従来合成できなかった、キサンテン環構造の2つの窒素原子が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物並びに、2つのフェニル環構造が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物を合成することができる。   According to the present invention, an aminobenzopyranoxanthene-based (ABPX) dye compound can be obtained with high yield. Furthermore, according to the production method of the present invention, an aminobenzopyranoxanthene-based (ABPX) dye compound in which two nitrogen atoms of the xanthene ring structure have an asymmetric substituent, and two phenyl ring structures, which could not be synthesized conventionally, It is possible to synthesize aminobenzopyranoxanthene (ABPX) dye compounds having an asymmetric substituent.

以下、本発明を詳細に説明する。   Hereinafter, the present invention will be described in detail.

まず、下記一般式(3)で表される化合物の製造方法について説明する。
本方法は、下記一般式(1)で表される化合物と下記一般式(2)で表される化合物とを縮合剤の存在下反応させることを特徴とする。
First, the manufacturing method of the compound represented by following General formula (3) is demonstrated.
This method is characterized by reacting a compound represented by the following general formula (1) and a compound represented by the following general formula (2) in the presence of a condensing agent.

Figure 2017088879
Figure 2017088879

[一般式(1)〜(3)中、R1は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1が結合して環を形成してもよく、又はR1が結合している窒素原子と共にヘテロ環を形成していてもよい。R2及びR4は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。] [In General Formulas (1) to (3), each R 1 independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms, or two R 1 bonded to each other. May form a ring, or may form a heterocycle together with the nitrogen atom to which R 1 is bonded. R 2 and R 4 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but a plurality of R 3 may be bonded to form a ring. R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. ]

一般式(1)及び(3)のR1の炭素数1〜6のアルキル基としては、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。 The alkyl group having 1 to 6 carbon atoms of R 1 in the general formulas (1) and (3) may be linear or branched and includes a cycloalkyl group and a bicycloalkyl group. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like.

一般式(1)及び(3)のR1の炭素数6〜14のアリール基としては、単環式であっても多環式であってもよく、ベンゼン環又は縮合環2個以上が単結合を介して結合した基、2価の有機基(例えば、ビニレン基等のアルケニレン基)を介して結合した基、及びヘテロアリール基も含まれる。具体的には、フェニル基、アルキルフェニル基、アルコキシフェニル基、1−ナフチル基、2−ナフチル基、1−アントラセニル基、2−アントラセニル基、9−アントラセニル基、2−ビフェニル基、3−ビフェニル基、4−ビフェニル基、チエニル基、ピリジル基、インドリル基等が挙げられる。アリール基の水素原子はハロゲン原子等で置換されていてもよい。これらのなかでも、フェニル基が好ましい。 The aryl group having 6 to 14 carbon atoms of R 1 in the general formulas (1) and (3) may be monocyclic or polycyclic, and two or more benzene rings or condensed rings are single. A group bonded through a bond, a group bonded through a divalent organic group (for example, an alkenylene group such as vinylene group), and a heteroaryl group are also included. Specifically, phenyl group, alkylphenyl group, alkoxyphenyl group, 1-naphthyl group, 2-naphthyl group, 1-anthracenyl group, 2-anthracenyl group, 9-anthracenyl group, 2-biphenyl group, 3-biphenyl group 4-biphenyl group, thienyl group, pyridyl group, indolyl group and the like. The hydrogen atom of the aryl group may be substituted with a halogen atom or the like. Among these, a phenyl group is preferable.

2つのR1が結合して環を形成している場合、2つのR1は酸素原子や硫黄原子等のヘテロ原子を介して結合してもよい。2つのR1が結合して環を形成している場合としては、R1が結合する窒素原子と共に表すと、例えば以下の構造が挙げられる。 When two R 1 are bonded to form a ring, the two R 1 may be bonded through a hetero atom such as an oxygen atom or a sulfur atom. As a case where two R 1s are bonded to form a ring, for example, the following structures may be mentioned when expressed together with the nitrogen atom to which R 1 is bonded.

Figure 2017088879
Figure 2017088879

1が結合している窒素原子と共にヘテロ環を形成している場合としては、R1が結合する窒素原子と共に表すと、例えば以下の構造が挙げられる。 As if together with the nitrogen atom to which R 1 is attached form a heterocyclic ring, it expressed together with the nitrogen atom to which R 1 is bonded, for example, the following structure.

Figure 2017088879
Figure 2017088879

一般式(1)及び(3)において2つのR1は、同一であっても異なっていてもよい。2つのR1が異なる場合としては、例えば、1つのR1はアルキル基であり、もう1つのR1はR1が結合している窒素原子と共にヘテロ環を形成している構造が挙げられる。 In the general formulas (1) and (3), two R 1 s may be the same or different. The case where two of R 1 are different, for example, one R 1 is an alkyl group, the other one R 1 can be mentioned structure forming a hetero ring together with the nitrogen atom to which R 1 is attached.

一般式(1)〜(3)中、R2及びR4のアルキル基としては、炭素数1〜12、好ましくは1〜6のものが挙げられ、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。なかでもR4のアルキル基は、メチル基、エチル基及びイソプロピル基が好ましい。
また、R2及びR4のアルキル基は置換基を有していてもよい。該置換基としては、メトキシ基、エトキシ基等のアルコキシ基;フェニル基等のアリール基;メトキシフェニル基、エトキシフェニル基等のアルコキシアリール基等が挙げられる。
上述したもののうち、メチル基、メトキシメチル基、ベンジル基、メトキシベンジル基等が好ましく、なかでも合成のしやすさからメチル基が特に好ましい。
In the general formulas (1) to (3), examples of the alkyl group represented by R 2 and R 4 include those having 1 to 12 carbon atoms, preferably 1 to 6 carbon atoms, which may be linear or branched. Groups and bicycloalkyl groups are also included. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like. Of these, the alkyl group of R 4 is preferably a methyl group, an ethyl group or an isopropyl group.
The alkyl group of R 2 and R 4 may have a substituent. Examples of the substituent include alkoxy groups such as methoxy group and ethoxy group; aryl groups such as phenyl group; alkoxyaryl groups such as methoxyphenyl group and ethoxyphenyl group.
Of those described above, a methyl group, a methoxymethyl group, a benzyl group, a methoxybenzyl group, and the like are preferable, and a methyl group is particularly preferable because of ease of synthesis.

一般式(1)〜(3)中、R2及びR4のアシル基としては、アセチル基、ピバロイル基、ベンゾイル基等が挙げられる。 In general formulas (1) to (3), examples of the acyl group represented by R 2 and R 4 include an acetyl group, a pivaloyl group, and a benzoyl group.

一般式(1)〜(3)中、R2及びR4のシリル基としては、トリメチルシリル基、トリエチルシリル基、トリイソプロピルシリル基、t−ブチルジメチルシリル基等のトリアルキルシリル基;t−ブチルジフェニルシリル基等が挙げられる。 In the general formulas (1) to (3), as the silyl group of R 2 and R 4 , a trialkylsilyl group such as a trimethylsilyl group, a triethylsilyl group, a triisopropylsilyl group, a t-butyldimethylsilyl group; A diphenylsilyl group etc. are mentioned.

一般式(1)〜(3)中、R3及びR8のハロゲン原子としては、フッ素原子、塩素原子、臭素原子、ヨウ素原子等が挙げられる。また、炭素数1〜6のアルキル基としては、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。
3又はR8が複数ある場合、それらはそれぞれ同一でも異なっていてもよい。
In general formulas (1) to (3), examples of the halogen atom represented by R 3 and R 8 include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Moreover, as a C1-C6 alkyl group, linear or branched may be sufficient and a cycloalkyl group and a bicycloalkyl group are also contained. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like.
When there are a plurality of R 3 or R 8 , they may be the same or different.

一般式(1)で表される化合物は、既報(非特許文献3)に従い合成することができるが、具体的には、例えば以下の化合物(1−1)〜(1−20)が挙げられる。   Although the compound represented by General formula (1) can be synthesize | combined according to a previous report (nonpatent literature 3), the following compounds (1-1)-(1-20) are specifically mentioned, for example. .

Figure 2017088879
Figure 2017088879

一般式(2)で表される化合物と、一般式(2)で表される化合物に対して2〜3倍当量、好ましくは約2倍当量の前記一般式(1)で表される化合物とを混合し、縮合剤の存在下反応する。ここで、縮合剤としては、特に限定されないが、硫酸、塩酸、リン酸、ポリリン酸、スルホン酸、メタンスルホン酸、エタンスルホン酸、トルエンスルホン酸、ベンゼンスルホン酸、トリフルオロ酢酸、トリフルオロメタンスルホン酸、ビストリフルオロメタンスルホンイミド、三塩化アルミニウム、塩化亜鉛、塩化ホスホリル、塩化鉄、塩化ジルコニウム、塩化ランタン、トリフルオロメタンスルホン酸ビスマス、トリフルオロメタンスルホン酸亜鉛、トリフルオロメタンスルホン酸イッテルビウム、トリフルオロメタンスルホン酸銅、トリフルオロメタンスルホン酸スズ、トリフルオロメタンスルホン酸ランタン、トリフルオロメタンスルホン酸ネオジム等が挙げられる。これらのなかでも、メタンスルホン酸、エタンスルホン酸が好ましく、メタンスルホン酸が特に好ましい。
この反応温度は、反応基質、縮合剤や用いる溶媒の種類により適宜選択されるが、通常、室温〜200℃程であり、室温〜150℃が好ましい。反応時間は、反応温度にもよるが、通常10分〜3日間程であり、加熱する場合においても同様の条件である。反応終了後、反応液を中和し、精製し、一般式(3)で表される化合物を得ることができる。
A compound represented by the general formula (2) and a compound represented by the general formula (1) in an amount of 2 to 3 times equivalent, preferably about 2 times equivalent to the compound represented by the general formula (2); And react in the presence of a condensing agent. Here, the condensing agent is not particularly limited, but sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid, sulfonic acid, methanesulfonic acid, ethanesulfonic acid, toluenesulfonic acid, benzenesulfonic acid, trifluoroacetic acid, trifluoromethanesulfonic acid. , Bistrifluoromethanesulfonimide, aluminum trichloride, zinc chloride, phosphoryl chloride, iron chloride, zirconium chloride, lanthanum chloride, bismuth trifluoromethanesulfonate, zinc trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate, copper trifluoromethanesulfonate, Examples thereof include tin trifluoromethanesulfonate, lanthanum trifluoromethanesulfonate, and neodymium trifluoromethanesulfonate. Among these, methanesulfonic acid and ethanesulfonic acid are preferable, and methanesulfonic acid is particularly preferable.
The reaction temperature is appropriately selected depending on the reaction substrate, the condensing agent, and the type of solvent used, but is usually about room temperature to 200 ° C, preferably room temperature to 150 ° C. Although the reaction time depends on the reaction temperature, it is usually about 10 minutes to 3 days, and the same conditions apply when heating. After completion of the reaction, the reaction solution is neutralized and purified to obtain the compound represented by the general formula (3).

一般式(3)で表される化合物は、水素イオンの授受により、以下に示される、中性型、モノカチオン型、ジカチオン型の3つの構造をとり得る。

Figure 2017088879
The compound represented by the general formula (3) can have the following three structures of a neutral type, a monocation type, and a dication type by the exchange of hydrogen ions.
Figure 2017088879

本発明において、一般式(3)で表される化合物には、これら3つの構造が含まれるものとする。   In the present invention, the compound represented by the general formula (3) includes these three structures.

本発明において、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基であり、一般式(3)で表される化合物を高収率で得るためには、2つのR4は同一であることが好ましい。
すなわち、R2が水素原子である場合、2つのR4はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基であることが好ましい。また、R2がアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である場合、2つのR4は共に水素原子であるか又は共にアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基であることが好ましい。
In the present invention, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group, in order to obtain a compound represented by the general formula (3) in a high yield. The two R 4 are preferably the same.
That is, when R 2 is a hydrogen atom, the two R 4 are preferably groups selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. When R 2 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group, two R 4 s are both hydrogen atoms or both are an alkyl group, an acyl group, a silyl group, and a tetrahydropyrani group. It is preferably a group selected from the following groups.

本発明ではこのようにR2及びR4の少なくとも一方をアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基で保護することにより、副生成物であるロドールの生成を抑制し、一般式(3)で表される化合物の収率を向上することができる。 In the present invention, by thus protecting at least one of R 2 and R 4 with a group selected from an alkyl group, an acyl group, a silyl group and a tetrahydropyranyl group, the production of rhodol as a by-product is suppressed, The yield of the compound represented by the general formula (3) can be improved.

次に、一般式(7)で表される化合物の製造方法について説明する。
本方法は、一般式(1)で表される化合物と一般式(2)で表される化合物とを縮合剤の存在下反応させ一般式(4)で表される化合物を得、次に、前記一般式(4)で表される化合物と一般式(5)で表される化合物とを縮合剤の存在下反応させ一般式(6)で表される化合物を得、さらに、前記一般式(6)で表される化合物を環化することを特徴とする。
Next, the manufacturing method of the compound represented by General formula (7) is demonstrated.
In this method, the compound represented by the general formula (1) and the compound represented by the general formula (2) are reacted in the presence of a condensing agent to obtain a compound represented by the general formula (4). The compound represented by the general formula (4) and the compound represented by the general formula (5) are reacted in the presence of a condensing agent to obtain a compound represented by the general formula (6). The compound represented by 6) is cyclized.

Figure 2017088879
Figure 2017088879

[一般式(1)〜(2)及び(4)〜(7)中、R1及びR5は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1同士もしくは2つのR5同士が結合して環を形成してもよく、又はR1もしくはR5が結合している窒素原子と共にヘテロ環を形成していてもよい。R2、R4及びR6は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3及びR7は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3同士又は複数のR7同士が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。R9は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R5とR9が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。oは0〜3の数を示す。pは0〜4の数を示す。] [In General Formulas (1) to (2) and (4) to (7), R 1 and R 5 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms. Or two R 1 s or two R 5 s may be bonded to form a ring, or a heterocycle may be formed together with the nitrogen atom to which R 1 or R 5 is bonded. . R 2 , R 4 and R 6 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 and R 7 are each independently a halogen atom or an alkyl group or a carboxyl group having 1 to 6 carbon atoms, may form a ring plurality of R 3 s or more R 7 are bonded to each other . R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. R 9 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but R 5 and R 9 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. o shows the number of 0-3. p shows the number of 0-4. ]

一般式(1)及び(4)〜(7)中、R1及びR5の炭素数1〜6のアルキル基としては、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。 In general formulas (1) and (4) to (7), the alkyl group having 1 to 6 carbon atoms of R 1 and R 5 may be linear or branched, and includes a cycloalkyl group and a bicycloalkyl group. It is. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like.

一般式(1)及び(4)〜(7)中、R1及びR5の炭素数6〜14のアリール基としては、単環式であっても多環式であってもよく、ベンゼン環又は縮合環2個以上が単結合を介して結合した基、2価の有機基(例えば、ビニレン基等のアルケニレン基)を介して結合した基、及びヘテロアリール基も含まれる。具体的には、フェニル基、アルキルフェニル基、アルコキシフェニル基、1−ナフチル基、2−ナフチル基、1−アントラセニル基、2−アントラセニル基、9−アントラセニル基、2−ビフェニル基、3−ビフェニル基、4−ビフェニル基、チエニル基、ピリジル基、インドリル基等が挙げられる。アリール基の水素原子はハロゲン原子等で置換されていてもよい。これらのなかでも、フェニル基が好ましい。 In general formulas (1) and (4) to (7), the aryl group having 6 to 14 carbon atoms of R 1 and R 5 may be monocyclic or polycyclic, and may be a benzene ring. Alternatively, a group in which two or more condensed rings are bonded via a single bond, a group bonded via a divalent organic group (for example, an alkenylene group such as vinylene group), and a heteroaryl group are also included. Specifically, phenyl group, alkylphenyl group, alkoxyphenyl group, 1-naphthyl group, 2-naphthyl group, 1-anthracenyl group, 2-anthracenyl group, 9-anthracenyl group, 2-biphenyl group, 3-biphenyl group 4-biphenyl group, thienyl group, pyridyl group, indolyl group and the like. The hydrogen atom of the aryl group may be substituted with a halogen atom or the like. Among these, a phenyl group is preferable.

2つのR1同士もしくは2つのR5同士が結合して環を形成している場合、2つのR1もしくは2つのR5は酸素原子や硫黄原子等のヘテロ原子を介して結合してもよい。2つのR1同士もしくはR5同士が結合して環を形成する場合としては、R1またはR5が結合する窒素原子と共に表すと、例えば以下の構造が挙げられる。 When two R 1 s or two R 5 s are bonded to form a ring, the two R 1 s or the two R 5 s may be bonded via a hetero atom such as an oxygen atom or a sulfur atom. . Examples of the case where two R 1 s or R 5 s are bonded to form a ring include the following structures when represented together with the nitrogen atom to which R 1 or R 5 is bonded.

Figure 2017088879
Figure 2017088879

1もしくはR5が結合している窒素原子と共にヘテロ環を形成している場合としては、R1が結合する窒素原子と共に表すと、例えば以下の構造が挙げられる。 As a case where a heterocycle is formed together with the nitrogen atom to which R 1 or R 5 is bonded, for example, the following structures can be cited when expressed together with the nitrogen atom to which R 1 is bonded.

Figure 2017088879
Figure 2017088879

一般式(1)及び(4)〜(7)において2つのR1及び2つのR5は、それぞれ同一であっても異なっていてもよい。2つのR1又は2つのR5が異なる場合としては、例えば、一方はアルキル基であり、もう一方はR1又はR5が結合している窒素原子と共にヘテロ環を形成している構造が挙げられる。 In the general formulas (1) and (4) to (7), two R 1 and two R 5 may be the same or different. Examples of the case where two R 1 or two R 5 are different include, for example, a structure in which one is an alkyl group and the other forms a heterocycle with the nitrogen atom to which R 1 or R 5 is bonded. It is done.

一般式(1)〜(2)及び(4)〜(7)中、R2、R4及びR6のアルキル基としては、炭素数1〜12、好ましくは1〜6のものが挙げられ、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。
また、R2、R4及びR6のアルキル基は置換基を有していてもよい。該置換基としては、メトキシ基、エトキシ基等のアルコキシ基;フェニル基等のアリール基;メトキシフェニル基、エトキシフェニル基等のアルコキシアリール基等が挙げられる。
上述したもののうち、メチル基、メトキシメチル基、ベンジル基、メトキシベンジル基等が好ましく、なかでも合成のしやすさからメチル基が特に好ましい。
In general formulas (1) to (2) and (4) to (7), examples of the alkyl group of R 2 , R 4 and R 6 include those having 1 to 12 carbon atoms, preferably 1 to 6 carbon atoms, It may be linear or branched and includes a cycloalkyl group and a bicycloalkyl group. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like.
Further, R 2, an alkyl group of R 4 and R 6 may have a substituent. Examples of the substituent include alkoxy groups such as methoxy group and ethoxy group; aryl groups such as phenyl group; alkoxyaryl groups such as methoxyphenyl group and ethoxyphenyl group.
Of those described above, a methyl group, a methoxymethyl group, a benzyl group, a methoxybenzyl group, and the like are preferable, and a methyl group is particularly preferable because of ease of synthesis.

一般式(1)〜(3)中、R2、R4及びR6のアシル基としては、アセチル基、ピバロイル基、ベンゾイル基等が挙げられる。 In general formulas (1) to (3), examples of the acyl group represented by R 2 , R 4, and R 6 include an acetyl group, a pivaloyl group, and a benzoyl group.

一般式(1)〜(2)及び(4)〜(7)中、R2、R4及びR6のシリル基としては、トリメチルシリル基、トリエチルシリル基、トリイソプロピルシリル基、t−ブチルジメチルシリル基等のトリアルキルシリル基;t−ブチルジフェニルシリル基等が挙げられる。 In the general formulas (1) to (2) and (4) to (7), as the silyl group of R 2 , R 4 and R 6 , trimethylsilyl group, triethylsilyl group, triisopropylsilyl group, t-butyldimethylsilyl A trialkylsilyl group such as a group; t-butyldiphenylsilyl group and the like.

一般式(1)及び(4)〜(7)中、R3、R7、R8及びR9のハロゲン原子としては、フッ素原子、塩素原子、臭素原子、ヨウ素原子等が挙げられる。また、炭素数1〜6のアルキル基としては、直鎖状でも分岐状でもよく、シクロアルキル基、ビシクロアルキル基も含まれる。具体的には、メチル基、エチル基、プロピル基、イソプロピル基、n−ブチル基、イソブチル基、s−ブチル基、t−ブチル基、ペンチル基、ヘキシル基等が挙げられる。
3、R7、R8又はR9が複数ある場合、それらはそれぞれ同一でも異なっていてもよい。
In general formulas (1) and (4) to (7), examples of the halogen atom for R 3 , R 7 , R 8, and R 9 include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. Moreover, as a C1-C6 alkyl group, linear or branched may be sufficient and a cycloalkyl group and a bicycloalkyl group are also contained. Specific examples include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group, isobutyl group, s-butyl group, t-butyl group, pentyl group, hexyl group and the like.
When there are a plurality of R 3 , R 7 , R 8 or R 9 , they may be the same or different.

一般式(1)で表される化合物としては、上記の一般式(3)で表される化合物の製造方法において例示したものと同様の化合物が挙げられる。   Examples of the compound represented by the general formula (1) include the same compounds as those exemplified in the method for producing the compound represented by the general formula (3).

一般式(1)で表される化合物と一般式(2)で表される化合物とをほぼ等モル量混合し、縮合剤の存在下反応する。縮合剤としては、特に限定されないが、硫酸、塩酸、リン酸、ポリリン酸、スルホン酸、メタンスルホン酸、エタンスルホン酸、トルエンスルホン酸、ベンゼンスルホン酸、トリフルオロ酢酸、トリフルオロメタンスルホン酸、ビストリフルオロメタンスルホンイミド、三塩化アルミニウム、塩化亜鉛、塩化ホスホリル、塩化鉄、塩化ジルコニウム、塩化ランタン、トリフルオロメタンスルホン酸ビスマス、トリフルオロメタンスルホン酸亜鉛、トリフルオロメタンスルホン酸イッテルビウム、トリフルオロメタンスルホン酸銅、トリフルオロメタンスルホン酸スズ、トリフルオロメタンスルホン酸ランタン、トリフルオロメタンスルホン酸ネオジム等が挙げられる。これらのなかでも、メタンスルホン酸、エタンスルホン酸が好ましく、メタンスルホン酸が特に好ましい。
このとき、ジクロロメタンのような溶媒の存在下反応を行ってもよい。
この反応温度は、反応基質、縮合剤や用いる溶媒の種類により適宜選択されるが、通常、室温〜200℃程であり、室温〜150℃が好ましい。反応時間は、反応温度にもよるが、通常10分〜3日間程であり、加熱する場合においても同様の条件である。反応終了後、反応液を中和し、精製し、一般式(4)で表される化合物を得ることができる。
The compound represented by the general formula (1) and the compound represented by the general formula (2) are mixed in approximately equimolar amounts and reacted in the presence of a condensing agent. The condensing agent is not particularly limited, but sulfuric acid, hydrochloric acid, phosphoric acid, polyphosphoric acid, sulfonic acid, methanesulfonic acid, ethanesulfonic acid, toluenesulfonic acid, benzenesulfonic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, bistrifluoromethane. Methanesulfonimide, aluminum trichloride, zinc chloride, phosphoryl chloride, iron chloride, zirconium chloride, lanthanum chloride, bismuth trifluoromethanesulfonate, zinc trifluoromethanesulfonate, ytterbium trifluoromethanesulfonate, copper trifluoromethanesulfonate, trifluoromethanesulfone Examples thereof include tin oxide, lanthanum trifluoromethanesulfonate, and neodymium trifluoromethanesulfonate. Among these, methanesulfonic acid and ethanesulfonic acid are preferable, and methanesulfonic acid is particularly preferable.
At this time, the reaction may be performed in the presence of a solvent such as dichloromethane.
The reaction temperature is appropriately selected depending on the reaction substrate, the condensing agent, and the type of solvent used, but is usually about room temperature to 200 ° C, preferably room temperature to 150 ° C. Although the reaction time depends on the reaction temperature, it is usually about 10 minutes to 3 days, and the same conditions apply when heating. After completion of the reaction, the reaction solution is neutralized and purified to obtain the compound represented by the general formula (4).

一般式(4)で表される化合物としては、例えば以下の化合物(4−1)〜(4−20)が挙げられる。   Examples of the compound represented by the general formula (4) include the following compounds (4-1) to (4-20).

Figure 2017088879
Figure 2017088879

この一般式(4)で表される化合物は、後述する一般式(7)で表される化合物において、キサンテン環構造の2つの窒素原子が非対称な置換基を有する化合物並びに、2つのフェニル環構造が非対称な置換基を有する化合物を合成する場合に有用な化合物である。   The compound represented by the general formula (4) includes a compound represented by the general formula (7) described later, a compound in which two nitrogen atoms of the xanthene ring structure have an asymmetric substituent, and two phenyl ring structures. Is useful when synthesizing a compound having an asymmetric substituent.

次に、一般式(4)で表される化合物と一般式(5)で表される化合物とをほぼ等モル量混合し、縮合剤の存在下反応する。   Next, the compound represented by the general formula (4) and the compound represented by the general formula (5) are mixed in approximately equimolar amounts and reacted in the presence of a condensing agent.

一般式(5)で表される化合物もまた、一般式(1)で表される化合物と同様に既報(非特許文献3)に従い合成することができる。具体的には、上記の化合物(1−1)〜(1−20)と同様の化合物(但し、化合物(1−1)〜(1−20)中のR2をR6で置き換えたものとする)が挙げられる。 Similarly to the compound represented by the general formula (1), the compound represented by the general formula (5) can also be synthesized according to a report (Non-patent Document 3). Specifically, compounds similar to the above compounds (1-1) to (1-20) (provided that R 2 in compounds (1-1) to (1-20) is replaced with R 6 ).

縮合剤としては、上記で例示した一般式(4)で表される化合物の合成に用いるものと同様のものが挙げられ、このときも、ジクロロメタンのような溶媒の存在下反応を行ってもよい。
このときの反応温度も、反応基質、縮合剤や用いる溶媒の種類により適宜選択されるが、通常、室温〜200℃程であり、室温〜150℃が好ましい。反応時間は反応温度にもよるが、通常10分〜3日間程であり、加熱する場合においても同様の条件である。反応終了後、反応液を中和し、精製し、一般式(6)で表される化合物を得ることができる。
Examples of the condensing agent include those similar to those used for the synthesis of the compound represented by the general formula (4) exemplified above, and at this time, the reaction may be performed in the presence of a solvent such as dichloromethane. .
The reaction temperature at this time is also appropriately selected depending on the reaction substrate, the condensing agent, and the type of solvent used, but is usually about room temperature to 200 ° C, preferably room temperature to 150 ° C. Although the reaction time depends on the reaction temperature, it is usually about 10 minutes to 3 days, and the same conditions apply when heating. After completion of the reaction, the reaction solution is neutralized and purified to obtain the compound represented by the general formula (6).

さらに、前記一般式(6)で表される化合物を環化することで、一般式(7)で表される化合物を得ることができる。このときの環化方法としては、例えば、R2、R4及びR6がアルキル基の場合、三臭化ホウ素のような脱アルキル化剤が挙げられる。またR2、R4及びR6がアルキル基やそれ以外の保護基を用いた場合の環化において、塩酸、酢酸、p-トルエンスルホン酸、p-トルエンスルホン酸ピリジニウム、トリフルオロ酢酸、メタンスルホン酸、水素化ジイソブチルアルミニウム、2,3-ジクロロ-5,6-ジシアノ-p-ベンゾキノンなどを用いることができる。反応終了後、反応液を中和し、精製し、一般式(7)で表される化合物を得ることができる。 Furthermore, the compound represented by the general formula (7) can be obtained by cyclizing the compound represented by the general formula (6). Examples of the cyclization method at this time include a dealkylating agent such as boron tribromide when R 2 , R 4 and R 6 are alkyl groups. In the cyclization when R 2 , R 4 and R 6 use an alkyl group or other protective group, hydrochloric acid, acetic acid, p-toluenesulfonic acid, pyridinium p-toluenesulfonate, trifluoroacetic acid, methanesulfone Acid, diisobutylaluminum hydride, 2,3-dichloro-5,6-dicyano-p-benzoquinone and the like can be used. After completion of the reaction, the reaction solution is neutralized and purified to obtain the compound represented by the general formula (7).

一般式(7)で表される化合物は、水素イオンの授受により、以下に示される、中性型、モノカチオン型、ジカチオン型の3つの構造をとり得る。   The compound represented by the general formula (7) can have the following three structures of a neutral type, a monocation type, and a dication type by the exchange of hydrogen ions.

Figure 2017088879
Figure 2017088879

本発明において、一般式(7)で表される化合物には、これら3つの構造が含まれるものとする。   In the present invention, the compound represented by the general formula (7) includes these three structures.

本発明において、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基であり、一般式(7)で表される化合物を高収率で得るためには、2つのR4は同一であることが好ましい。 In the present invention, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group, in order to obtain a compound represented by the general formula (7) in a high yield. The two R 4 are preferably the same.

一般式(7)で表される化合物において、R1及びR5、R3及びR7並びにR8及びR9は互いに同一であっても異なっていてもよい。R1及びR5、R3及びR7並びにR8及びR9のうち少なくとも一組が異なる化合物は、R2及びR4が水素原子である従来の合成法では合成することができなかった。本発明の方法は、R2及びR4の少なくとも一方をアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基で保護することにより、キサンテン環構造の2つの窒素原子が非対称な(互いに異なる)置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物並びに、2つのフェニル環構造が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物を合成することができる。
また、対称な置換基を有するABPXは、プロトンの付加などの外的刺激に対するアンテナ部位である二つのスピロ環の電子的環境 (例えば、酸性度や求核性など)が同じであるため、中性型からジカチオン型へ速やかに構造変換し、発色や発光の色彩のコントラストが得られにくかった。その反面、キサンテン環構造やフェニル環構造に電子供与性や電子受容性の異なった非対称な置換基を有するABPXは、二つのスピロ環の電子的環境が異なるため、加えるプロトンの濃度に応じて、スピロ環部位の開閉が段階的に起こる。その結果、中性型からモノカチオン型を経てジカチオン型へ構造変換が段階的かつ可逆的となり、3つの平衡種それぞれに由来する発色や発光の色彩のコントラストが強くなる。本性質により、ABPXは色素一分子で、白色発光や黒色を示す特徴をもった色素化合物となる。
In the compound represented by the general formula (7), R 1 and R 5 , R 3 and R 7 , and R 8 and R 9 may be the same or different from each other. Compounds in which at least one set of R 1 and R 5 , R 3 and R 7 and R 8 and R 9 is different cannot be synthesized by a conventional synthesis method in which R 2 and R 4 are hydrogen atoms. In the method of the present invention, at least one of R 2 and R 4 is protected with a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group, whereby two nitrogen atoms of the xanthene ring structure are asymmetric ( It is possible to synthesize aminobenzopyranoxanthene-based (ABPX) dye compounds having substituents (different from each other) and aminobenzopyranoxanthene-based (ABPX) dye compounds having substituents with asymmetric two phenyl ring structures.
In addition, ABPX with symmetric substituents has the same electronic environment (for example, acidity and nucleophilicity) of the two spiro rings that are antenna sites for external stimuli such as proton addition. The structure was quickly converted from the sex type to the dicationic type, and it was difficult to obtain the contrast of color development and luminescence. On the other hand, ABPX, which has asymmetric substituents with different electron-donating and electron-accepting properties in the xanthene ring structure or phenyl ring structure, differs in the electronic environment of the two spiro rings. The opening and closing of the spiro ring site occurs in stages. As a result, the structural conversion from the neutral type to the monocation type through the dication type becomes stepwise and reversible, and the contrast of the color development and luminescence color derived from each of the three equilibrium species becomes stronger. Due to this property, ABPX is a single dye molecule, and becomes a dye compound having the characteristics of white light emission and black color.

このようなキサンテン環構造の2つの窒素原子が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物並びに、2つのフェニル環構造が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物としては、例えば以下の化合物(7−1)〜(7−139)が挙げられる。   An aminobenzopyranoxanthene dye (ABPX) dye compound in which two nitrogen atoms of the xanthene ring structure have an asymmetric substituent, and an aminobenzopyranoxane xanthene system in which two phenyl ring structures have an asymmetric substituent ( Examples of the ABPX) dye compound include the following compounds (7-1) to (7-139).

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

Figure 2017088879
Figure 2017088879

以下、実施例及び比較例を挙げて、本願発明をさらに詳細に説明するが、本願発明は下記の例に制限されるものではない。   EXAMPLES Hereinafter, although an Example and a comparative example are given and this invention is demonstrated in detail, this invention is not restrict | limited to the following example.

1H−NMR及び13C−NMRは、Varian NMR System 600(Agilent Technologies社製)を用いて測定した。
MSスペクトルは、JMS-700 MStation(日本電子社製)を用いて測定した。
吸収スペクトルは、JASCO V-570(日本分光社製)を用いて測定した。
蛍光スペクトルは、Hitachi F-4500(日立ハイテクサイエンス社製)を用いて測定した。
1 H-NMR and 13 C-NMR were measured using a Varian NMR System 600 (manufactured by Agilent Technologies).
The MS spectrum was measured using JMS-700 MStation (manufactured by JEOL Ltd.).
The absorption spectrum was measured using JASCO V-570 (manufactured by JASCO Corporation).
The fluorescence spectrum was measured using Hitachi F-4500 (manufactured by Hitachi High-Tech Science).

[実施例1]
2-(2-ヒドロキシ-4-ピロリジニルベンゾイル)安息香酸 (1-A, 0.28 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジメトキシベンゼン (2-B, 0.14 mmol,和光純薬工業株式会社より購入) の混合物をメタンスルホン酸 (0.7 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX105-a及び化合物ABPX105-bを分離した。この際に化合物ABPX105-aが先に流出し、その後化合物ABPX-105-bが流出した。収率はABPX105-a,ABPX105-b合わせて 73%であった。反応式は以下に示す。
[Example 1]
2- (2-hydroxy-4-pyrrolidinylbenzoyl) benzoic acid (1-A, 0.28 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1 , 3-Dimethoxybenzene (2-B, 0.14 mmol, purchased from Wako Pure Chemical Industries, Ltd.) was added to methanesulfonic acid (0.7 mL), stirred for 24 hours at 110 ° C, and then the reaction mixture was saturated with sodium bicarbonate. The solution was made basic by adding an aqueous solution and extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX105-a and compound ABPX105-b. At this time, compound ABPX105-a flowed out first, and then compound ABPX-105-b flowed out. The yield was 73% for both ABPX105-a and ABPX105-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX105-aのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9, 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
UV/Vis: λmax = 595 nm (ジカチオン型、pH 2.2−0.2 Mリン酸水素ナトリウム/5 M 塩酸の混合水溶液).
Data for compound ABPX105-a:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d ), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9 , 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
UV / Vis: λ max = 595 nm (dicationic type, pH 2.2-0.2 M sodium hydrogen phosphate / 5 M hydrochloric acid mixed solution).

化合物ABPX105-bのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13(1H, s), 6.91-6.90 (2H, m), 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0, 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13 (1H, s), 6.91-6.90 (2H, m) , 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0 , 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

[実施例2]
2-(2-メトキシ-4-ピロリジニルベンゾイル)安息香酸 (1-B, 0.34 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及びレゾルシノール(2-A, 0.18 mmol,関東化学株式会社より購入) の混合物をメタンスルホン酸 (1.0 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて液を塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX105-a及び化合物ABPX105-bを分離した。この際に化合物ABPX105-aが先に流出し、その後化合物ABPX105-bが流出した。収率はABPX105-a,ABPX1-5-b合わせて 73%であった。反応式は以下に示す。
[Example 2]
2- (2-Methoxy-4-pyrrolidinylbenzoyl) benzoic acid (1-B, 0.34 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and resorcinol (2-A, 0.18 mmol, purchased from Kanto Chemical Co., Inc.) was added to methanesulfonic acid (1.0 mL) and stirred for 24 hours at 110 ° C. And extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX105-a and compound ABPX105-b. At this time, compound ABPX105-a flowed out first, and then compound ABPX105-b flowed out. The yield was 73% for both ABPX105-a and ABPX1-5-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX105-aのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9, 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-a:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d ), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9 , 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

化合物ABPX105-bのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13(1H, s), 6.91-6.90 (2H, m), 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0, 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13 (1H, s), 6.91-6.90 (2H, m) , 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0 , 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

[比較例1]
2-(2-ヒドロキシ-4-ピロリジニルベンゾイル)安息香酸 (1-A, 163 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及びレゾルシノール(2-A, 83 mmol,関東化学株式会社より購入)の混合物をメタンスルホン酸 (0.7 mL) に加え、4時間120℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX105-a及び化合物ABPX105-bを分離した。この際に化合物ABPX105-aが先に流出し、その後化合物ABPX105-bが流出した。収率はABPX105-a、ABPX105-b合わせて 35%であった。反応式は以下に示す。反応時間を10時間としても、化合物ABPX105-a、ABPX105-bの収率は合わせて36%に留まった。
[Comparative Example 1]
2- (2-hydroxy-4-pyrrolidinylbenzoyl) benzoic acid (1-A, 163 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and resorcinol (2-A, 83 mmol, purchased from Kanto Chemical Co., Inc.) was added to methanesulfonic acid (0.7 mL), stirred for 4 hours at 120 ° C, and then basified with saturated aqueous sodium hydrogen carbonate solution. And extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX105-a and compound ABPX105-b. At this time, compound ABPX105-a flowed out first, and then compound ABPX105-b flowed out. The yield was 35% for both ABPX105-a and ABPX105-b. The reaction formula is shown below. Even when the reaction time was 10 hours, the combined yields of the compounds ABPX105-a and ABPX105-b remained at 36%.

Figure 2017088879
Figure 2017088879

実施例1〜2及び比較例1の化合物ABPX105-a、ABPX105-bの収率(合算値)と副生成物であるロドールの収率を以下の表1にまとめる。   The yields (total values) of the compounds ABPX105-a and ABPX105-b of Examples 1 and 2 and Comparative Example 1 and the yield of by-product rhodol are summarized in Table 1 below.

Figure 2017088879
Figure 2017088879

本発明の製造方法により目的化合物である化合物ABPX105-a、ABPX105-bの収率は、比較例1に比べ2倍以上に向上した。また、化合物ABPX105-a、ABPX105-bに対するロドールの生成比率が低下することがわかった。   The yields of the target compounds ABPX105-a and ABPX105-b by the production method of the present invention were improved more than twice compared with Comparative Example 1. Moreover, it turned out that the production | generation ratio of the rhodol with respect to compound ABPX105-a and ABPX105-b falls.

[実施例3]
2-(2-ヒドロキシ-4-ピロリジニルベンゾイル)安息香酸 (1-A, 0.17 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジエトキシベンゼン (2-C, 0.081 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX105-a及び化合物ABPX105-bを分離した。この際に化合物ABPX105-aが先に流出し、その後化合物ABPX105-bが流出した。収率はABPX105-a、ABPX105-b合わせて 56%であった。反応式は以下に示す。
[Example 3]
2- (2-hydroxy-4-pyrrolidinylbenzoyl) benzoic acid (1-A, 0.17 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1 , 3-Diethoxybenzene (2-C, 0.081 mmol, literature: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380.) After stirring at 110 ° C. for 24 hours, the reaction mixture was basified with saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX105-a and compound ABPX105-b. At this time, compound ABPX105-a flowed out first, and then compound ABPX105-b flowed out. The yield was 56% for both ABPX105-a and ABPX105-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX105-aのデータ:
1H-NMR (CDCl3/TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
13C-NMR (CDCl3/TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9, 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-a:
1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
13 C-NMR (CDCl 3 / TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9, 83.6 , 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

化合物ABPX105-bのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13(1H, s), 6.91-6.90 (2H, m), 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0, 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13 (1H, s), 6.91-6.90 (2H, m) , 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0 , 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

[実施例4]
2-(2-ヒドロキシ-4-ピロリジニルベンゾイル)安息香酸 (1-A, 0.015 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.074 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX105-a及び化合物ABPX105-bを分離した。この際に化合物ABPX105-aが先に流出し、その後化合物ABPX105-bが流出した。収率はABPX105-a、ABPX105-b合わせて 74%であった。反応式は以下に示す。
[Example 4]
2- (2-hydroxy-4-pyrrolidinylbenzoyl) benzoic acid (1-A, 0.015 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1 , 3-diisopropoxybenzene (2-D, 0.074 mmol, literature: synthesized by the method described in Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380.) 5 mL), and after stirring for 24 hours at 110 ° C., the reaction mixture was basified with a saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX105-a and compound ABPX105-b. At this time, compound ABPX105-a flowed out first, and then compound ABPX105-b flowed out. The yield was 74% for both ABPX105-a and ABPX105-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX105-aのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9, 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-a:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.79 (2H, d), 7.60 (2H, d), 7.51 (2H, d), 7.13 (1H, s), 7.10 (2H, d ), 6.51 (2H, d), 6.37 (2H, d), 6.23 (2H, dd), 6.05 (1H, s), 3.25 (8H, m), 2.0 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 169.2, 153.1, 152.6, 152.2, 149.6, 135.1, 129.7, 128.6, 127.7, 126.6, 124.6, 123.9, 116.3, 108.9, 105.1, 104.2, 97.9 , 83.6, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

化合物ABPX105-bのデータ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13(1H, s), 6.91-6.90 (2H, m), 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0, 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.
Data for compound ABPX105-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.81-7.80 (2H, m), 7.43-7.40 (4H, m), 7.13 (1H, s), 6.91-6.90 (2H, m) , 6.50 (d, 2H), 6.37 (d, 2H), 6.22 (2H, dd), 5.98 (1H, s), 3.27 (8H, m), 2.10-1.99 (8H, m).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 168.9, 153.2, 152.8, 152.3, 149.6, 134.1, 129.3, 128.5, 128.5, 127.2, 124.9, 123.4, 116.3, 108.8, 105.3, 104.3, 98.0 , 83.3, 47.6, 29.7, 25.5.
LR-MS (FAB), Found: 661.

[参考例1]
反応温度以外は実施例4と同様の条件で、反応温度を室温から130℃まで種々に変えて化合物ABPX105-a及び化合物ABPX105-bの合成を行なった。いずれの反応温度でも、化合物ABPX105-a及び化合物ABPX105-bの生成を確認したが、反応温度110℃において化合物ABPX105-a及び化合物ABPX105-bが最も収率高く得られることがわかった。
[Reference Example 1]
Compound ABPX105-a and compound ABPX105-b were synthesized under the same conditions as in Example 4 except that the reaction temperature was changed from room temperature to 130 ° C. Although formation of compound ABPX105-a and compound ABPX105-b was confirmed at any reaction temperature, it was found that compound ABPX105-a and compound ABPX105-b were obtained with the highest yield at a reaction temperature of 110 ° C.

[実施例5]
2-(2-ヒドロキシ-4-ピペリジニルベンゾイル)安息香酸 (1-C, 0.17 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.081 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX106-a及び化合物ABPX106-bを分離した。この際に化合物ABPX106-aが先に流出し、その後化合物ABPX106-bが流出した。収率は化合物ABPX106-a及び化合物ABPX106-b合わせて 53%であった。反応式は以下に示す。
[Example 5]
2- (2-hydroxy-4-piperidinylbenzoyl) benzoic acid (1-C, 0.17 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1 , 3-diisopropoxybenzene (2-D, 0.081 mmol, synthesized by the method described in Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380.) 5 mL), and after stirring for 24 hours at 110 ° C., the reaction mixture was basified with a saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX106-a and compound ABPX106-b. At this time, compound ABPX106-a flowed out first, and then compound ABPX106-b flowed out. The yield was 53% in total for compound ABPX106-a and compound ABPX106-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX106-aのデータ:
1H-NMR (CDCl3, 600 MHz): δ 7.81-7.84 (m, 2 H), 7.63 (ddd, 2 H, J = 7.8, 7.8, 1.2 Hz), 7.54 (ddd, 2 H, J = 7.8, 7.8, 0.6 Hz), 7.15 (s, 1 H), 7.10-7.13 (m, 2 H), 6.73 (d, 2 H, J = 2.4 Hz), 6.59 (dd, 2 H, J = 8.4, 1.8 Hz), 6.54 (d, 2 H, J = 9.6 Hz ), 6.53 (d, 2 H, J = 9.1 Hz), 3.25-3.27 (m, 8 H), 1.67-1.71 (m, 8 H), 1.58-1.64 (m, 4 H).
13C-NMR (CDCl3, 600 MHz): δ 169.19, 153.50, 153.08, 153.07, 152.41, 152.15, 135.16, 129.80, 128.36, 127.75, 126.35, 124.67, 123.91, 116.27, 112.21, 107.81, 104.31, 101.76, 82.95, 49.32, 25.40, 24.30.
LRMS (ESI) Found 668.
Data for compound ABPX106-a:
1 H-NMR (CDCl 3 , 600 MHz): δ 7.81-7.84 (m, 2 H), 7.63 (ddd, 2 H, J = 7.8, 7.8, 1.2 Hz), 7.54 (ddd, 2 H, J = 7.8 , 7.8, 0.6 Hz), 7.15 (s, 1 H), 7.10-7.13 (m, 2 H), 6.73 (d, 2 H, J = 2.4 Hz), 6.59 (dd, 2 H, J = 8.4, 1.8 Hz), 6.54 (d, 2 H, J = 9.6 Hz), 6.53 (d, 2 H, J = 9.1 Hz), 3.25-3.27 (m, 8 H), 1.67-1.71 (m, 8 H), 1.58 -1.64 (m, 4 H).
13 C-NMR (CDCl 3 , 600 MHz): δ 169.19, 153.50, 153.08, 153.07, 152.41, 152.15, 135.16, 129.80, 128.36, 127.75, 126.35, 124.67, 123.91, 116.27, 112.21, 107.81, 104.31, 101.76, 82.95 , 49.32, 25.40, 24.30.
LRMS (ESI) Found 668.

化合物ABPX106-bのデータ:
1H-NMR (CDCl3, 600 MHz): δ 7.82-7.86 (m, 2 H), 7.43-7.48 (m, 4 H), 7.18 (s, 1 H), 6.90-6.94 (m, 2 H), 6.75 (m, 2 H), 6.57-6.60 (m, 4 H), 6.04 (s, 1 H), 3.86-3.87 (m, 8 H), 3.21-3.23 (m, 8 H).
13C-NMR (CDCl3, 600 MHz): δ 168.76, 153.11, 153.04, 152.54, 152.10, 134.28, 129.49, 128.54, 128.50, 126.86, 125.09, 123.28, 116.35, 111.68, 109.46, 104.47, 101.85, 82.25, 66.63, 48.25, 29.73
LRMS (ESI) Found 688.
Data for compound ABPX106-b:
1 H-NMR (CDCl 3 , 600 MHz): δ 7.82-7.86 (m, 2 H), 7.43-7.48 (m, 4 H), 7.18 (s, 1 H), 6.90-6.94 (m, 2 H) , 6.75 (m, 2 H), 6.57-6.60 (m, 4 H), 6.04 (s, 1 H), 3.86-3.87 (m, 8 H), 3.21-3.23 (m, 8 H).
13 C-NMR (CDCl 3 , 600 MHz): δ 168.76, 153.11, 153.04, 152.54, 152.10, 134.28, 129.49, 128.54, 128.50, 126.86, 125.09, 123.28, 116.35, 111.68, 109.46, 104.47, 101.85, 82.25, 66.63 , 48.25, 29.73
LRMS (ESI) Found 688.

[実施例6]
2-(2-ヒドロキシ-4-モルフォリニルベンゾイル)安息香酸(1-D, 0.17 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.080 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、24時間110℃で攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX107-a及び化合物ABPX107-bを分離した。この際に化合物ABPX107-aが先に流出し、その後化合物ABPX107-bが流出した。収率は化合物ABPX107-a及び化合物ABPX107-b合わせて 66%であった。反応式は以下に示す。
[Example 6]
2- (2-hydroxy-4-morpholinylbenzoyl) benzoic acid (1-D, 0.17 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1 , 3-diisopropoxybenzene (2-D, 0.080 mmol, synthesized by the method described in Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380.) 5 mL), and after stirring for 24 hours at 110 ° C., the reaction mixture was basified with a saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. After drying the organic layer with magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX107-a and compound ABPX107-b. At this time, compound ABPX107-a flowed out first, and then compound ABPX107-b flowed out. The yield was 66% in total for compound ABPX107-a and compound ABPX107-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX107-aのデータ:
1H-NMR (CDCl3, 600 MHz): δ 7.82-7.84 (m, 2 H), 7.64 (ddd, 2 H, J = 7.2, 7.2, 1.2 Hz), 7.56 (ddd, 2 H, J = 7.8, 7.8, 1.2 Hz), 7.17 (s, 1 H), 7.11-7.12 (m, 2 H), 6.75 (d, 2 H, J = 0.6 Hz), 6.58-6.62 (m, 4 H), 6.12 (s, 1 H), 3.86-3.87 (m, 8 H), 3.22-3.24 (m, 8 H).
13C-NMR (CDCl3, 600 MHz): δ 160.03, 152.96, 152.30, 152.12, 135.26, 129.93, 128.55, 127.78, 124.79, 123.82, 116.36, 111.73, 104.42, 101.81, 66.63, 48.23.
LRMS (ESI) Found 692.
Data for compound ABPX107-a:
1 H-NMR (CDCl 3 , 600 MHz): δ 7.82-7.84 (m, 2 H), 7.64 (ddd, 2 H, J = 7.2, 7.2, 1.2 Hz), 7.56 (ddd, 2 H, J = 7.8 , 7.8, 1.2 Hz), 7.17 (s, 1 H), 7.11-7.12 (m, 2 H), 6.75 (d, 2 H, J = 0.6 Hz), 6.58-6.62 (m, 4 H), 6.12 ( s, 1 H), 3.86-3.87 (m, 8 H), 3.22-3.24 (m, 8 H).
13 C-NMR (CDCl 3 , 600 MHz): δ 160.03, 152.96, 152.30, 152.12, 135.26, 129.93, 128.55, 127.78, 124.79, 123.82, 116.36, 111.73, 104.42, 101.81, 66.63, 48.23.
LRMS (ESI) Found 692.

化合物ABPX107-bのデータ:
1H-NMR (CDCl3, 600 MHz): δ 7.84-7.88 (m, 2 H), 7.44-7.49 (M, 4), 7.56 (ddd, 2 H, J = 7.8, 7.8, 1.2 Hz), 7.17 (s, 1 H), 7.11-7.12 (m, 2 H), 6.75 (d, 2 H, J = 0.6 Hz), 6.58-6.62 (m, 4 H), 6.12 (s, 1 H), 3.86-3.87 (m, 8 H), 3.22-3.24 (m, 8 H).
13C-NMR (CDCl3, 600 MHz): δ 160.03, 152.96, 152.30, 152.12, 135.26, 129.93, 128.55, 127.78, 124.79, 123.82, 116.36, 111.73, 104.42, 101.81, 66.63, 48.23.
LRMS (ESI) Found 692.
Data for compound ABPX107-b:
1 H-NMR (CDCl 3 , 600 MHz): δ 7.84-7.88 (m, 2 H), 7.44-7.49 (M, 4), 7.56 (ddd, 2 H, J = 7.8, 7.8, 1.2 Hz), 7.17 (s, 1 H), 7.11-7.12 (m, 2 H), 6.75 (d, 2 H, J = 0.6 Hz), 6.58-6.62 (m, 4 H), 6.12 (s, 1 H), 3.86- 3.87 (m, 8 H), 3.22-3.24 (m, 8 H).
13 C-NMR (CDCl 3 , 600 MHz): δ 160.03, 152.96, 152.30, 152.12, 135.26, 129.93, 128.55, 127.78, 124.79, 123.82, 116.36, 111.73, 104.42, 101.81, 66.63, 48.23.
LRMS (ESI) Found 692.

[実施例7]
8-(2-カルボキシメチルベンゾイル)-7-ヒドロキシ-1,1-ジメチル-N-メチルキノリン (1-E, 0.17 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.082 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、室温で12時間攪拌を行い、続けて12時間110℃で攪拌後,反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX101-a及び化合物ABPX101-bを分離した。この際に化合物ABPX101-aが先に流出し、その後化合物ABPX101-bが流出した。収率は化合物ABPX101-a及び化合物ABPX101-b合わせて 62%であった。反応式は以下に示す。
[Example 7]
8- (2-Carboxymethylbenzoyl) -7-hydroxy-1,1-dimethyl-N-methylquinoline (1-E, 0.17 mmol, literature: Kamino et al., Org. Lett., 2014, 16, 258. And 1,3-diisopropoxybenzene (2-D, 0.082 mmol, literature: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. ) Was added to methanesulfonic acid (5 mL), stirred at room temperature for 12 hours, then stirred for 12 hours at 110 ° C., basified with saturated aqueous sodium hydrogen carbonate solution, and extracted with chloroform. did. After the organic layer was dried over magnesium sulfate, the solvent was distilled off under reduced pressure. The resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX101-a and compound ABPX101-b. At this time, compound ABPX101-a flowed out first, and then compound ABPX101-b flowed out. The yield was 62% in total for compound ABPX101-a and compound ABPX101-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX101-aのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.79 (d, 2H, J = 7.4 Hz), 7.61 (ddd, 2H, J = 7.5, 7.5 Hz, 1.2 Hz), 7.52 (ddd, 2H, J = 7.5, 7.5, 1.2 Hz), 7.12 (d, 2H, J = 7.5 Hz), 7.09 (s, 1H), 6.38 (s, 2H), 6.37 (s, 2H), 5.97 (s, 1H), 3.13-3.23 (m, 4H), 2.96 (s, 6H), 1.64 (t, 4H, 5.8 Hz), 1.04 (s, 6H), 0.95 (s, 6H).
13C-NMR (CDCl3, 500 MHz): δ169.25, 153.13, 152.04, 151.06, 147.32, 134.91, 129.59, 128.43, 127.53, 126.69, 124.42, 123.97, 123.92, 116.27, 104.83, 103.96, 96.92, 83.92, 47.27, 39.09, 36.42, 31.60, 30.90, 30.05, 30.03.
LRMS (ESI) Found 359.
Data for compound ABPX101-a:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.79 (d, 2H, J = 7.4 Hz), 7.61 (ddd, 2H, J = 7.5, 7.5 Hz, 1.2 Hz), 7.52 (ddd, 2H, J = 7.5, 7.5, 1.2 Hz), 7.12 (d, 2H, J = 7.5 Hz), 7.09 (s, 1H), 6.38 (s, 2H), 6.37 (s, 2H), 5.97 (s, 1H), 3.13- 3.23 (m, 4H), 2.96 (s, 6H), 1.64 (t, 4H, 5.8 Hz), 1.04 (s, 6H), 0.95 (s, 6H).
13 C-NMR (CDCl 3 , 500 MHz): δ169.25, 153.13, 152.04, 151.06, 147.32, 134.91, 129.59, 128.43, 127.53, 126.69, 124.42, 123.97, 123.92, 116.27, 104.83, 103.96, 96.92, 83.92, 47.27, 39.09, 36.42, 31.60, 30.90, 30.05, 30.03.
LRMS (ESI) Found 359.

化合物ABPX101-bのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.82 (dd, 2H, J = 6.3, 1.7 Hz), 7.44 (td, 2H, J = 6.9, 1.7 Hz), 7.42 (td, 2H, J = 7.5,1.8 Hz), 7.09 (s, 1H), 6.87 (dd, 2H, J = 5.8, 1.7 Hz), 6.38 (s, 2H), 6.37 (s, 2H), 5.91 (s, 1H), 3.32-3.22 (m, 4H), 2.95 (s, 6H), 1.64-1.59 (m, 4H), 1.04 (s, 6H), 0.93 (s, 6H).
13C-NMR (CDCl3, 500 MHz): δ 168.88, 153.17, 152.14, 151.27, 147.30, 133.96, 129.16, 128.39, 128.28, 127.23, 124.81, 123.90, 123.33, 116.26, 104.98, 104.07, 96.96, 83.56, 47.27, 39.10, 36.43, 31.59, 30.04, 30.01.
LRMS (ESI) Found 359.
Data for compound ABPX101-b:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.82 (dd, 2H, J = 6.3, 1.7 Hz), 7.44 (td, 2H, J = 6.9, 1.7 Hz), 7.42 (td, 2H, J = 7.5 , 1.8 Hz), 7.09 (s, 1H), 6.87 (dd, 2H, J = 5.8, 1.7 Hz), 6.38 (s, 2H), 6.37 (s, 2H), 5.91 (s, 1H), 3.32-3.22 (m, 4H), 2.95 (s, 6H), 1.64-1.59 (m, 4H), 1.04 (s, 6H), 0.93 (s, 6H).
13 C-NMR (CDCl 3 , 500 MHz): δ 168.88, 153.17, 152.14, 151.27, 147.30, 133.96, 129.16, 128.39, 128.28, 127.23, 124.81, 123.90, 123.33, 116.26, 104.98, 104.07, 96.96, 83.56, 47.27 , 39.10, 36.43, 31.59, 30.04, 30.01.
LRMS (ESI) Found 359.

[実施例8]
8-(2-カルボキシメチルベンゾイル)-9-ヒドロキシ-1,1-ジメチル-N-メチルキノリン (1-F, 0.16 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.078 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、室温で12時間攪拌を行い、続けて12時間110℃で攪拌後,反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX102-a及び化合物ABPX102-bを分離した。この際に化合物ABPX102-aが先に流出し、その後化合物ABPX102-bが流出した。収率は化合物ABPX102-a及び化合物ABPX102-b合わせて 34%であった。反応式は以下に示す。
[Example 8]
8- (2-Carboxymethylbenzoyl) -9-hydroxy-1,1-dimethyl-N-methylquinoline (1-F, 0.16 mmol, literature: Kamino et al., Org. Lett., 2014, 16, 258. And 1,3-diisopropoxybenzene (2-D, 0.078 mmol, literature: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. ) Was added to methanesulfonic acid (5 mL), stirred at room temperature for 12 hours, then stirred for 12 hours at 110 ° C., basified with saturated aqueous sodium hydrogen carbonate solution, and extracted with chloroform. did. After drying the organic layer with magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX102-a and compound ABPX102-b. At this time, compound ABPX102-a flowed out first, and then compound ABPX102-b flowed out. The yield of the compound ABPX102-a and compound ABPX102-b was 34%. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX102-aのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.78 (d, 2H, J = 7.5 Hz), 7.60 (ddd, 2H, J = 7.5, 7.5, 1.2 Hz), 7.50 (ddd, 2H, J = 7.5, 7.5, 1.2 Hz), 7.21 (s, 1H), 7.14 (d, 2H, J = 7.5 Hz), 6.40 (d, 2H, J = 9.2 Hz), 6.30 (d, 2H, J = 8.5 Hz), 6.04 (s, 1H), 3.21 (t, 4H, J = 5.5 Hz), 2.87 (s, 6H), 1.88 (t, 4H, J = 5.4 Hz), 1.64 (s, 12 H).
13C-NMR (CDCl3, 500 MHz): δ 169.09, 153.01, 151.68, 151.13, 148.51, 134.89, 129.61, 126.84, 125.96, 124.63, 123.98, 117.19, 116.37, 108.35, 107.27, 103.71, 84.05, 47.70, 40.54, 40.15, 32.44, 29.85, 29.73.
LRMS (ESI) Found 359.
Data for compound ABPX102-a:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.78 (d, 2H, J = 7.5 Hz), 7.60 (ddd, 2H, J = 7.5, 7.5, 1.2 Hz), 7.50 (ddd, 2H, J = 7.5 , 7.5, 1.2 Hz), 7.21 (s, 1H), 7.14 (d, 2H, J = 7.5 Hz), 6.40 (d, 2H, J = 9.2 Hz), 6.30 (d, 2H, J = 8.5 Hz), 6.04 (s, 1H), 3.21 (t, 4H, J = 5.5 Hz), 2.87 (s, 6H), 1.88 (t, 4H, J = 5.4 Hz), 1.64 (s, 12 H).
13 C-NMR (CDCl 3 , 500 MHz): δ 169.09, 153.01, 151.68, 151.13, 148.51, 134.89, 129.61, 126.84, 125.96, 124.63, 123.98, 117.19, 116.37, 108.35, 107.27, 103.71, 84.05, 47.70, 40.54 , 40.15, 32.44, 29.85, 29.73.
LRMS (ESI) Found 359.

化合物ABPX102-bのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.84-7.80 (m, 2H), 7.46 (m, 2H), 7.45 (m, 2H), 7.22 (s, 1H), 6.98-6.95 (m, 2H), 6.38 (d, J = 9.2 Hz, 2H), 6.29 (d, J = 9.2 Hz, 2H), 6.01 (s, 1H), 3.26-3.16 (m, 4H), 2.87 (s, 6H), 1.91-1.86 (m, 4H), 1.65 (s, 6H), 1.62 (s, 6H).
13C-NMR (CDCl3, 500 MHz): δ 168.74, 153.07, 151.69, 151.36, 148.50, 133.97, 129.27, 127.60, 127.42, 125.91, 125.00, 123.48, 117.25, 116.34, 108.30, 107.45, 103.77, 83.74, 47.69, 40.53, 40.15, 32.43, 29.89, 29.68.
LRMS (ESI) Found 359.
Data for compound ABPX102-b:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.84-7.80 (m, 2H), 7.46 (m, 2H), 7.45 (m, 2H), 7.22 (s, 1H), 6.98-6.95 (m, 2H ), 6.38 (d, J = 9.2 Hz, 2H), 6.29 (d, J = 9.2 Hz, 2H), 6.01 (s, 1H), 3.26-3.16 (m, 4H), 2.87 (s, 6H), 1.91 -1.86 (m, 4H), 1.65 (s, 6H), 1.62 (s, 6H).
13 C-NMR (CDCl 3 , 500 MHz): δ 168.74, 153.07, 151.69, 151.36, 148.50, 133.97, 129.27, 127.60, 127.42, 125.91, 125.00, 123.48, 117.25, 116.34, 108.30, 107.45, 103.77, 83.74, 47.69 , 40.53, 40.15, 32.43, 29.89, 29.68.
LRMS (ESI) Found 359.

[実施例9]
9-(2-カルボキシベンゾイル)-8-ヒドロキシジュロリジン(1-G, 0.17 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.078 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、室温で12時間攪拌を行い、続けて12時間110℃で攪拌後,反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX103-a及び化合物ABPX103-bを分離した。この際に化合物ABPX103-aが先に流出し、その後化合物ABPX103-bが流出した。収率は化合物ABPX103-a及び化合物ABPX103-b合わせて 56%であった。反応式は以下に示す。
[Example 9]
9- (2-Carboxybenzoyl) -8-hydroxyjulolidine (1-G, 0.17 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and 1,3 -Diisopropoxybenzene (2-D, 0.078 mmol, literature: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380.) The mixture was stirred at room temperature for 12 hours and then stirred at 110 ° C. for 12 hours. The reaction mixture was basified with saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. After drying the organic layer over magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX103-a and compound ABPX103-b. At this time, compound ABPX103-a flowed out first, and then compound ABPX103-b flowed out. The yield was 56% in total for compound ABPX103-a and compound ABPX103-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX103-aのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.76 (d, 2H, J = 8.0 Hz), 7.59 (ddd, J = 7.4, 7.4, 1.2 Hz, 2H), 7.49 (ddd, 2H, J = 7.2, 7.2, 1.2 Hz), 7.17 (s, 1H), 7.12 (d, 2H, J = 7.5 Hz), 6.05 (s, 2H), 5.96 (s, 1H), 3.18 (t, 4H, J = 5.5 Hz), 3.13 (t, 4H, J = 5.5 Hz), 2.94 (t, 4H, J = 6.6 Hz), 2.54-2.44 (m, 4H), 2.04-2.00 (m, 4H), 1.88-1.84 (m, 4H).
13C-NMR (CDCl3, 500 MHz): δ 169.25, 153.13, 152.00, 147.89, 144.65, 134.88, 129.50, 127.50, 126.80, 124.60, 124.42, 124.05, 117.87, 116.00, 107.28, 104.95, 104.19, 84.26, 49.81, 49.35, 29.68, 27.27, 21.68, 21.13, 20.95.
LRMS (ESI) Found: 357.
Data for compound ABPX103-a:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.76 (d, 2H, J = 8.0 Hz), 7.59 (ddd, J = 7.4, 7.4, 1.2 Hz, 2H), 7.49 (ddd, 2H, J = 7.2 , 7.2, 1.2 Hz), 7.17 (s, 1H), 7.12 (d, 2H, J = 7.5 Hz), 6.05 (s, 2H), 5.96 (s, 1H), 3.18 (t, 4H, J = 5.5 Hz ), 3.13 (t, 4H, J = 5.5 Hz), 2.94 (t, 4H, J = 6.6 Hz), 2.54-2.44 (m, 4H), 2.04-2.00 (m, 4H), 1.88-1.84 (m, 4H).
13 C-NMR (CDCl 3 , 500 MHz): δ 169.25, 153.13, 152.00, 147.89, 144.65, 134.88, 129.50, 127.50, 126.80, 124.60, 124.42, 124.05, 117.87, 116.00, 107.28, 104.95, 104.19, 84.26, 49.81 , 49.35, 29.68, 27.27, 21.68, 21.13, 20.95.
LRMS (ESI) Found: 357.

化合物ABPX103-bのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.80 (d, 2H, J = 6.3 Hz), 7.42 (t, 2H, J = 6.9 Hz), 7.42 (t, 2H, J = 6.9 Hz), 7.18 (s, 1H), 6.90 (d, 2H, J = 5.2 Hz), 6.04 (s, 2H), 5.91 (s, 1H), 3.17 (t, 4H, J = 6.9 Hz), 3.12 (t, 4H, J = 6.9 Hz), 2.99-2.88 (m, 4H), 2.49-2.42 (m, 4H), 2.07-1.97 (m, 4H), 1.89-1.80 (m, 4H):
13C-NMR (CDCl3, 500 MHz): δ 168.87, 153.20, 152.09, 148.11, 144.64, 133.93, 129.09, 128.25, 127.39, 124.82, 124.56, 123.45, 117.85, 116.00, 107.37, 105.10, 104.34, 83.92, 49.82, 49.37, 27.28, 21.70, 21.14, 20.96.
HRMS (ESI) Found: 357.
Data for compound ABPX103-b:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.80 (d, 2H, J = 6.3 Hz), 7.42 (t, 2H, J = 6.9 Hz), 7.42 (t, 2H, J = 6.9 Hz), 7.18 (s, 1H), 6.90 (d, 2H, J = 5.2 Hz), 6.04 (s, 2H), 5.91 (s, 1H), 3.17 (t, 4H, J = 6.9 Hz), 3.12 (t, 4H, J = 6.9 Hz), 2.99-2.88 (m, 4H), 2.49-2.42 (m, 4H), 2.07-1.97 (m, 4H), 1.89-1.80 (m, 4H):
13 C-NMR (CDCl 3 , 500 MHz): δ 168.87, 153.20, 152.09, 148.11, 144.64, 133.93, 129.09, 128.25, 127.39, 124.82, 124.56, 123.45, 117.85, 116.00, 107.37, 105.10, 104.34, 83.92, 49.82 , 49.37, 27.28, 21.70, 21.14, 20.96.
HRMS (ESI) Found: 357.

[実施例10]
1,1,7,7,-テトラメチル-8-ヒドロキシジュロリジン(1-H, 0.14 mmol, 文献: Kamino et al., Org. Lett., 2014, 16, 258. 記載の手法により合成) 及び1,3-ジイソプロポキシベンゼン (2-D, 0.068 mmol,文献: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. 記載の手法により合成) の混合物をメタンスルホン酸 (5 mL) に加え、室温で12時間攪拌を行い、続けて12時間110℃で攪拌後,反応液に飽和炭酸水素ナトリウム水溶液を加えて塩基性にし、クロロホルムで抽出した。有機層を硫酸マグネシウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX108-a及び化合物ABPX108-bを分離した。この際に化合物ABPX108-aが先に流出し、その後化合物ABPX108-bが流出した。収率は化合物ABPX108-a及び化合物ABPX108-b合わせて 17%であった。反応式は以下に示す。
[Example 10]
1,1,7,7, -tetramethyl-8-hydroxyjulolidine (1-H, 0.14 mmol, literature: synthesized by the method described in Kamino et al., Org. Lett., 2014, 16, 258.) and A mixture of 1,3-diisopropoxybenzene (2-D, 0.068 mmol, literature: Kamino et al., Biorg. Med. Chem. Lett., 2008, 18, 4380. (5 mL) and stirring at room temperature for 12 hours, followed by stirring for 12 hours at 110 ° C., the reaction solution was basified with saturated aqueous sodium hydrogen carbonate solution, and extracted with chloroform. After drying the organic layer with magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX108-a and compound ABPX108-b. At this time, compound ABPX108-a flowed out first, and then compound ABPX108-b flowed out. The yield was 17% in total for compound ABPX108-a and compound ABPX108-b. The reaction formula is shown below.

Figure 2017088879
Figure 2017088879

化合物ABPX108-aのデータ:
1H-NMR (CDCl3, 500 MHz): δ 7.80-8.83 (m, 2H), 7.62 (ddd, 2H, J = 7.8, 7.8, 1.2 Hz), 7.52 (ddd, 2H, J = 7.2, 7.2, 0.6 Hz), 7.18 (s, 1H), 7.17 (d, 2H, J = 7.8 Hz), 6.31 (m, 2H), 5.99 (s, 1H), 3.12-3.19 (m, 8 H), 1.87-1.89 (m, 4H), 1.65-1.67 (m, 16 H), 1.27 (m, 4H), 1.04 (m, 4H), 0.96 (m, 4H).
LRMS (ESI), Found 824.
化合物ABPX108-aのデータ:
LRMS (ESI), Found 824.
Data for compound ABPX108-a:
1 H-NMR (CDCl 3 , 500 MHz): δ 7.80-8.83 (m, 2H), 7.62 (ddd, 2H, J = 7.8, 7.8, 1.2 Hz), 7.52 (ddd, 2H, J = 7.2, 7.2, 0.6 Hz), 7.18 (s, 1H), 7.17 (d, 2H, J = 7.8 Hz), 6.31 (m, 2H), 5.99 (s, 1H), 3.12-3.19 (m, 8 H), 1.87-1.89 (m, 4H), 1.65-1.67 (m, 16 H), 1.27 (m, 4H), 1.04 (m, 4H), 0.96 (m, 4H).
LRMS (ESI), Found 824.
Data for compound ABPX108-a:
LRMS (ESI), Found 824.

実施例3〜10で得られた各化合物の収率(合算値)と副生成物であるロドールの収率を以下の表2にまとめる。   The yield (total value) of each compound obtained in Examples 3 to 10 and the yield of rhodol as a by-product are summarized in Table 2 below.

Figure 2017088879
Figure 2017088879

実施例5〜10及び比較例1で得られた各化合物を、2.5体積%トリフルオロ酢酸を含むクロロホルムに溶解して、吸収スペクトル及び蛍光スペクトルを測定した。本測定条件において、各化合物はジカチオン型構造である。
蛍光量子収率は、エタノール中におけるローダミンBを基準物質(Φfl = 0.73)とし、相対法により算出した。
Each compound obtained in Examples 5 to 10 and Comparative Example 1 was dissolved in chloroform containing 2.5% by volume of trifluoroacetic acid, and an absorption spectrum and a fluorescence spectrum were measured. In this measurement condition, each compound has a dicationic structure.
The fluorescence quantum yield was calculated by a relative method using rhodamine B in ethanol as a reference substance (Φ fl = 0.73).

Figure 2017088879
Figure 2017088879

特に実施例5及び実施例9において、蛍光量子収率の高い化合物を得ることができた。   In particular, in Example 5 and Example 9, a compound having a high fluorescence quantum yield could be obtained.

[実施例11]
2-(4-ジエチルアミノ-2-ヒドロキシベンゾイル)安息香酸 (3-A, 1.0 mmol, 文献: Kamino et al., Chem. Commun., 2010, 46, 9013. 記載の手法により合成) および1,3-ジメトキシベンゼン (2-B, 1.0 mmol,和光純薬工業株式会社より購入) の混合物を8%のメタンスルホン酸を含むジクロロメタン溶液 (4.35 mL) に加え、室温で2時間攪拌後,反応液に飽和炭酸水素ナトリウム水溶液を加えて液を塩基性にし、クロロホルムで抽出した。有機層を硫酸ナトリウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物BF3A2Bを分離した。収率は65%であった。
続いて、3-[4-(ジエチルアミノ)-2-ヒドロキシフェニル]-3-[2,4-ジメトキシフェニル]-1-イソベンゾフラノン (BF3A2B, 0.25 mmol) および2-(2-ヒドロキシ-4-ピロリジニルベンゾイル)安息香酸(1-A, 0.25 mmmol) の混合物を10%のメタンスルホン酸を含むジクロロメタン溶液 (4.0 mL) に加え、室温で2時間攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて液を塩基性にし、クロロホルムで抽出した。有機層を硫酸ナトリウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX500-bを分離した。収率は37%であった。
[Example 11]
2- (4-Diethylamino-2-hydroxybenzoyl) benzoic acid (3-A, 1.0 mmol, literature: synthesized by the method described in Kamino et al., Chem. Commun., 2010, 46, 9013.) and 1,3 -Dimethoxybenzene (2-B, 1.0 mmol, purchased from Wako Pure Chemical Industries, Ltd.) was added to a dichloromethane solution (4.35 mL) containing 8% methanesulfonic acid, and stirred at room temperature for 2 hours. Saturated aqueous sodium hydrogen carbonate solution was added to basify the solution, and the mixture was extracted with chloroform. The organic layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound BF3A2B. The yield was 65%.
Subsequently, 3- [4- (diethylamino) -2-hydroxyphenyl] -3- [2,4-dimethoxyphenyl] -1-isobenzofuranone (BF3A2B, 0.25 mmol) and 2- (2-hydroxy-4- A mixture of pyrrolidinylbenzoyl) benzoic acid (1-A, 0.25 mmmol) was added to a dichloromethane solution (4.0 mL) containing 10% methanesulfonic acid, and the mixture was stirred at room temperature for 2 hours. Was added to make the solution basic and extracted with chloroform. The organic layer was dried over sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX500-b. The yield was 37%.

Figure 2017088879
Figure 2017088879

化合物BF3A2Bの構造データ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.94-7.92 (1H, m), 7.65-7.62 (1H, m), 7.53-7.50 (1H, m), 7.42-7.40 (1H, m), 7.02 (1H, d, J = 8.5 Hz), 6.92 (1H, d, J = 8.8 Hz), 6.40 (1H, m), 6.38 (1H, dd, J = 8.5, 2.3 Hz), 6.34 (1H, dd, J = 7.0, 2.6 Hz), 6.13 (1H, dd, J = 8.8, 2.6 Hz), 3.76 (3H, s), 3.41 (3H, s), 3.33 (4H, q, J = 7.3 Hz), 1.15 (6H, t, J = 7.3 Hz).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 169.4, 161.9, 159.1, 156.6, 151.5, 149.7, 133.1, 130.5, 128.6, 127.2, 125.4, 124.1, 119.2, 111.3, 103.9, 103.0, 100.8, 100.2, 91.8, 55.5, 55.3, 44.3, 12.6.
LR-MS (FAB), Found: 434.
Structural data for compound BF3A2B:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.94-7.92 (1H, m), 7.65-7.62 (1H, m), 7.53-7.50 (1H, m), 7.42-7.40 (1H, m), 7.02 (1H, d, J = 8.5 Hz), 6.92 (1H, d, J = 8.8 Hz), 6.40 (1H, m), 6.38 (1H, dd, J = 8.5, 2.3 Hz), 6.34 ( 1H, dd, J = 7.0, 2.6 Hz), 6.13 (1H, dd, J = 8.8, 2.6 Hz), 3.76 (3H, s), 3.41 (3H, s), 3.33 (4H, q, J = 7.3 Hz ), 1.15 (6H, t, J = 7.3 Hz).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 169.4, 161.9, 159.1, 156.6, 151.5, 149.7, 133.1, 130.5, 128.6, 127.2, 125.4, 124.1, 119.2, 111.3, 103.9, 103.0, 100.8 , 100.2, 91.8, 55.5, 55.3, 44.3, 12.6.
LR-MS (FAB), Found: 434.

化合物ABPX500-bの構造データ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.82-7.80 (2H, m), 7.44-7.40 (4H, m), 7.14(1H, s), 6.93-6.90 (2H, m), 6.50-6.47 (3H, m), 6.37 (1H, d, J = 2.3 Hz), 6.31 (1H, dd, J = 8.8, 2.5 Hz), 6.22 (1H, dd, J = 8.8, 2.3 Hz), 5.98 (1H, s), 3.36 (4H, q, J = 7.0 Hz), 3.30-3.28 (4H, m), 2.02-2.00 (4H, m), 1.16 (6H, t, J = 7.0 Hz).
600 MHz 13C-NMR (CDCl3/TMS) δ (ppm): 168.9, 168.8, 153.2, 153.2, 153.1, 152.8, 152.3, 152.1, 149.7, 149.6, 134.1, 134.0, 129.2, 128.6, 128.5, 127.3, 127.2, 124.9, 123.4, 123.3, 108.8, 108.4, 105.3, 105.1, 104.3, 97.9, 97.7, 83.3, 83.2, 47.6, 44.5, 25.5, 12.5.
LR-MS (FAB), Found: 663.
UV/Vis: λmax = 594 nm (ジカチオン型、pH 2.5−0.2 Mクエン酸ナトリウム/1 M 塩酸の混合水溶液).
Structural data for compound ABPX500-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.82-7.80 (2H, m), 7.44-7.40 (4H, m), 7.14 (1H, s), 6.93-6.90 (2H, m) , 6.50-6.47 (3H, m), 6.37 (1H, d, J = 2.3 Hz), 6.31 (1H, dd, J = 8.8, 2.5 Hz), 6.22 (1H, dd, J = 8.8, 2.3 Hz), 5.98 (1H, s), 3.36 (4H, q, J = 7.0 Hz), 3.30-3.28 (4H, m), 2.02-2.00 (4H, m), 1.16 (6H, t, J = 7.0 Hz).
600 MHz 13 C-NMR (CDCl 3 / TMS) δ (ppm): 168.9, 168.8, 153.2, 153.2, 153.1, 152.8, 152.3, 152.1, 149.7, 149.6, 134.1, 134.0, 129.2, 128.6, 128.5, 127.3, 127.2 , 124.9, 123.4, 123.3, 108.8, 108.4, 105.3, 105.1, 104.3, 97.9, 97.7, 83.3, 83.2, 47.6, 44.5, 25.5, 12.5.
LR-MS (FAB), Found: 663.
UV / Vis: λ max = 594 nm (dicationic type, pH 2.5-0.2 M sodium citrate / 1 M hydrochloric acid mixed aqueous solution).

[実施例12]
3-[4-(ジエチルアミノ)-2-ヒドロキシフェニル]-3-[2,4-ジメトキシフェニル]-1-イソベンゾフラノン (BF3A2B, 0.23 mmol) および2-(4-ジブチルアミノ-4-メトキシベンゾイル)安息香酸 (4-A, 0.23 mmol,関東化学株式会社より購入) の混合物を10%のメタンスルホン酸を含むジクロロメタン溶液 (5.0 mL) に加え、室温で2時間攪拌後、反応液に飽和炭酸水素ナトリウム水溶液を加えて液を塩基性にし、クロロホルムで抽出した。有機層を硫酸ナトリウムで乾燥した後、減圧で溶媒を留去し、得られた粗生成物をクロロホルムに溶かし、シリカゲルカラムクロマトグラフィーにかけ、化合物ABPX501-bを分離した。
[Example 12]
3- [4- (Diethylamino) -2-hydroxyphenyl] -3- [2,4-dimethoxyphenyl] -1-isobenzofuranone (BF3A2B, 0.23 mmol) and 2- (4-dibutylamino-4-methoxybenzoyl) ) Add a mixture of benzoic acid (4-A, 0.23 mmol, purchased from Kanto Chemical Co., Inc.) to a dichloromethane solution (5.0 mL) containing 10% methanesulfonic acid and stir at room temperature for 2 hours. An aqueous sodium hydrogen solution was added to basify the solution, and the mixture was extracted with chloroform. After drying the organic layer with sodium sulfate, the solvent was distilled off under reduced pressure, and the resulting crude product was dissolved in chloroform and subjected to silica gel column chromatography to separate compound ABPX501-b.

Figure 2017088879
Figure 2017088879

化合物ABPX501-bの構造データ:
600 MHz 1H-NMR (CDCl3/TMS) δ (ppm): 7.82-7.80 (2H, m), 7.44-7.40 (4H, m), 7.14 (1H, s), 6.93-6.90 (2H, m), 6.48-6.43 (4H, m), 6.31 (1H, m), 6.28 (1H, dd, J = 9.1, 2.3 Hz), 5.97 (1H, s), 3.35 (4H, q, J = 7.0 Hz), 3.30-3.23 (4H, m), 1.59-1.53 (4H, m), 1.37-1.31 (4H, m), 1.16 (6H, t, J = 7.3 Hz), 0.94 (t, 6H, J = 7.3 Hz).
LR-MS (FAB), Found: 721.
Structural data for compound ABPX501-b:
600 MHz 1 H-NMR (CDCl 3 / TMS) δ (ppm): 7.82-7.80 (2H, m), 7.44-7.40 (4H, m), 7.14 (1H, s), 6.93-6.90 (2H, m) , 6.48-6.43 (4H, m), 6.31 (1H, m), 6.28 (1H, dd, J = 9.1, 2.3 Hz), 5.97 (1H, s), 3.35 (4H, q, J = 7.0 Hz), 3.30-3.23 (4H, m), 1.59-1.53 (4H, m), 1.37-1.31 (4H, m), 1.16 (6H, t, J = 7.3 Hz), 0.94 (t, 6H, J = 7.3 Hz) .
LR-MS (FAB), Found: 721.

[参考例2]
実施例1において、縮合剤としてメタンスルホン酸の代わりにトリフルオロメタンスルホン酸を用いた以外は実施例1と同様にして化合物ABPX105-a、ABPX105-bを得た。収率は化合物ABPX105-a、ABPX105-b合わせて 9%であり、ロドールの収率は77%であった。
[Reference Example 2]
In Example 1, compounds ABPX105-a and ABPX105-b were obtained in the same manner as in Example 1 except that trifluoromethanesulfonic acid was used instead of methanesulfonic acid as the condensing agent. The yield of the compounds ABPX105-a and ABPX105-b was 9%, and the yield of rhodol was 77%.

本発明の製造方法により、高収率でアミノベンゾピラノキサンテン系(ABPX)色素化合物を得ることができる。キサンテン環構造の窒素部位を縮環したアミノベンゾピラノキサンテン系(ABPX)色素化合物は、発光効率が高く着色料や顔料、染色剤としての各種色素材料、蛍光イメージング色素、色素増感型太陽電池等様々な分野に有用な化合物として期待される。
さらに、本発明の製造方法によれば、従来合成できなかった、キサンテン環構造並びにフェニル環構造が非対称な置換基を有するアミノベンゾピラノキサンテン系(ABPX)色素化合物を合成することができる。キサンテン環構造やフェニル環構造に電子供与性や電子受容性の異なった非対称な置換基を有するABPXは、二つのスピロ環の電子的環境が異なるため、加えるプロトンの濃度に応じて、スピロ環部位の開閉が段階的に起こる。その結果、中性型からモノカチオン型を経てジカチオン型へ構造変換が段階的かつ可逆的となり、3つの平衡種それぞれに由来する発色や発光の色彩のコントラストが強くなる。本性質により、ABPXは色素一分子で、白色発光や黒色を示す特徴をもった色素化合物となり、オプトエレクトロニクス材料やセンシング材料としても期待される。
By the production method of the present invention, an aminobenzopyranoxanthene (ABPX) dye compound can be obtained in high yield. Aminobenzopyranoxanthene (ABPX) dye compounds fused with a nitrogen moiety of the xanthene ring structure have high luminous efficiency, coloring materials, pigments, various dye materials as dyes, fluorescent imaging dyes, dye-sensitized solar cells It is expected as a useful compound in various fields.
Furthermore, according to the production method of the present invention, it is possible to synthesize an aminobenzopyranoxanthene-based (ABPX) dye compound having a substituent with an asymmetric xanthene ring structure and phenyl ring structure, which could not be synthesized conventionally. ABPX, which has asymmetric substituents with different electron-donating and electron-accepting properties in the xanthene ring structure or phenyl ring structure, differs in the electronic environment of the two spiro rings. Opening and closing of this occurs in stages. As a result, the structural conversion from the neutral type to the monocation type through the dication type becomes stepwise and reversible, and the contrast of the color development and luminescence color derived from each of the three equilibrium species becomes stronger. Due to this property, ABPX is a single molecule of dye, and becomes a dye compound with the characteristics of white light emission and black, and is expected as an optoelectronic material and sensing material.

Claims (4)

下記一般式(1)で表される化合物と下記一般式(2)で表される化合物とを縮合剤の存在下反応させることを特徴とする、下記一般式(3)で表される化合物の製造方法。
Figure 2017088879
[一般式(1)〜(3)中、R1は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1が結合して環を形成してもよく、又はR1が結合している窒素原子と共にヘテロ環を形成していてもよい。R2及びR4は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。]
A compound represented by the following general formula (3), characterized in that a compound represented by the following general formula (1) and a compound represented by the following general formula (2) are reacted in the presence of a condensing agent. Production method.
Figure 2017088879
[In General Formulas (1) to (3), each R 1 independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms, or two R 1 bonded to each other. May form a ring, or may form a heterocycle together with the nitrogen atom to which R 1 is bonded. R 2 and R 4 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but a plurality of R 3 may be bonded to form a ring. R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. ]
一般式(1)で表される化合物と一般式(2)で表される化合物とを縮合剤の存在下反応させ一般式(4)で表される化合物を得、
次に、前記一般式(4)で表される化合物と一般式(5)で表される化合物とを縮合剤の存在下反応させ一般式(6)で表される化合物を得、
さらに、前記一般式(6)で表される化合物を環化することを特徴とする、一般式(7)で表される化合物の製造方法。
Figure 2017088879
[一般式(1)〜(2)及び(4)〜(7)中、R1及びR5は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1同士もしくは2つのR5同士が結合して環を形成してもよく、又はR1もしくはR5が結合している窒素原子と共にヘテロ環を形成していてもよい。R2、R4及びR6は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3及びR7は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3同士又は複数のR7同士が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。R9は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R5とR9が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。oは0〜3の数を示す。pは0〜4の数を示す。]
The compound represented by general formula (1) and the compound represented by general formula (2) are reacted in the presence of a condensing agent to obtain a compound represented by general formula (4),
Next, the compound represented by the general formula (4) and the compound represented by the general formula (5) are reacted in the presence of a condensing agent to obtain a compound represented by the general formula (6).
Furthermore, the compound represented by the general formula (6) is cyclized. A method for producing the compound represented by the general formula (7).
Figure 2017088879
[In General Formulas (1) to (2) and (4) to (7), R 1 and R 5 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms. Or two R 1 s or two R 5 s may be bonded to form a ring, or a heterocycle may be formed together with the nitrogen atom to which R 1 or R 5 is bonded. . R 2 , R 4 and R 6 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 and R 7 are each independently a halogen atom or an alkyl group or a carboxyl group having 1 to 6 carbon atoms, may form a ring plurality of R 3 s or more R 7 are bonded to each other . R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. R 9 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but R 5 and R 9 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. o shows the number of 0-3. p shows the number of 0-4. ]
一般式(7)で表される化合物。
Figure 2017088879
[一般式(7)中、R1及びR5は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1同士もしくは2つのR5同士が結合して環を形成してもよく、又はR1もしくはR5が結合している窒素原子と共にヘテロ環を形成していてもよい。R3及びR7は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3同士又は複数のR7同士が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。R9は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R5とR9が結合して環を形成してもよい。但し、R1及びR5、R3及びR7並びにR8及びR9のうち少なくとも一組は、互いに異なるものを示す。mは0〜3の数を示す。nは0〜4の数を示す。oは0〜3の数を示す。pは0〜4の数を示す。]
The compound represented by General formula (7).
Figure 2017088879
[In the general formula (7), R 1 and R 5 each independently represent a hydrogen atom, or an alkyl group or an aryl group having 6 to 14 carbon atoms having 1 to 6 carbon atoms, the two R 1 together or two R 5 may be bonded to each other to form a ring, or a heterocycle may be formed together with the nitrogen atom to which R 1 or R 5 is bonded. R 3 and R 7 are each independently a halogen atom or an alkyl group or a carboxyl group having 1 to 6 carbon atoms, may form a ring plurality of R 3 s or more R 7 are bonded to each other . R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. R 9 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but R 5 and R 9 may be bonded to form a ring. However, at least one of R 1 and R 5 , R 3 and R 7 and R 8 and R 9 is different from each other. m shows the number of 0-3. n shows the number of 0-4. o shows the number of 0-3. p shows the number of 0-4. ]
一般式(4)で表される化合物。
Figure 2017088879
[一般式(4)中、R1は、それぞれ独立に水素原子、炭素数1〜6のアルキル基もしくは炭素数6〜14のアリール基を示すか、2つのR1が結合して環を形成してもよく、又はR1が結合している窒素原子と共にヘテロ環を形成していてもよい。R2及びR4は、それぞれ独立に水素原子又はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基を示す。但し、R2及びR4の少なくとも一方はアルキル基、アシル基、シリル基及びテトラヒドロピラニル基より選ばれる基である。R3は、ハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、複数のR3が結合して環を形成してもよい。R8は、それぞれ独立にハロゲン原子、炭素数1〜6のアルキル基又はカルボキシル基を示すが、R1とR8が結合して環を形成してもよい。mは0〜3の数を示す。nは0〜4の数を示す。]
The compound represented by General formula (4).
Figure 2017088879
[In General Formula (4), each R 1 independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 14 carbon atoms, or two R 1 's bonded to form a ring. Or may form a heterocycle together with the nitrogen atom to which R 1 is bonded. R 2 and R 4 each independently represent a hydrogen atom or a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. However, at least one of R 2 and R 4 is a group selected from an alkyl group, an acyl group, a silyl group, and a tetrahydropyranyl group. R 3 represents a halogen atom, an alkyl group having 1 to 6 carbon atoms or a carboxyl group, but a plurality of R 3 may be bonded to form a ring. R 8 independently represents a halogen atom, an alkyl group having 1 to 6 carbon atoms, or a carboxyl group, but R 1 and R 8 may be bonded to form a ring. m shows the number of 0-3. n shows the number of 0-4. ]
JP2016216617A 2015-11-05 2016-11-04 Method for Producing Aminobenzopyranoxanthene (ABPX) Dye Compound Active JP6869524B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015217899 2015-11-05
JP2015217899 2015-11-05

Publications (2)

Publication Number Publication Date
JP2017088879A true JP2017088879A (en) 2017-05-25
JP6869524B2 JP6869524B2 (en) 2021-05-12

Family

ID=58770438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016216617A Active JP6869524B2 (en) 2015-11-05 2016-11-04 Method for Producing Aminobenzopyranoxanthene (ABPX) Dye Compound

Country Status (1)

Country Link
JP (1) JP6869524B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016050894A (en) * 2014-09-01 2016-04-11 国立研究開発法人理化学研究所 Gas detection material and its application
JP2020045437A (en) * 2018-09-20 2020-03-26 株式会社パイロットコーポレーション Thermochromic ink composition for writing instruments and writing instrument including the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52273A (en) * 1975-06-20 1977-01-05 Yamada Kagaku Kogyo Kk Process for preparation of fluoran compound
US8134017B1 (en) * 2010-12-02 2012-03-13 Riken Compound and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52273A (en) * 1975-06-20 1977-01-05 Yamada Kagaku Kogyo Kk Process for preparation of fluoran compound
US8134017B1 (en) * 2010-12-02 2012-03-13 Riken Compound and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAMINO, SHINICHIRO; MURAKAMI, MIHO; TANIOKA, MASARU; SHIRASAKI, YOSHINAO; WATANABE, KEIKO; HORIGOME,: "Design and Syntheses of Highly Emissive Aminobenzopyrano-xanthene Dyes in the Visible and Far-Red Re", ORGANIC LETTERS, vol. 16(1), JPN6020029974, 2014, pages 258 - 261, ISSN: 0004326395 *
TANIOKA, MASARU; KAMINO, SHINICHIRO; MURANAKA, ATSUYA; OOYAMA, YOUSUKE; OTA, HIROMI; SHIRASAKI, YOSH: "Reversible Near-Infrared/Blue Mechanofluorochromism of Aminobenzopyranoxanthene", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 137(20), JPN6020029975, 2015, pages 6436 - 6439, ISSN: 0004326396 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016050894A (en) * 2014-09-01 2016-04-11 国立研究開発法人理化学研究所 Gas detection material and its application
JP2020045437A (en) * 2018-09-20 2020-03-26 株式会社パイロットコーポレーション Thermochromic ink composition for writing instruments and writing instrument including the same
JP7178843B2 (en) 2018-09-20 2022-11-28 株式会社パイロットコーポレーション Thermochromic ink composition for writing instrument and writing instrument using the same

Also Published As

Publication number Publication date
JP6869524B2 (en) 2021-05-12

Similar Documents

Publication Publication Date Title
JP6916769B2 (en) Platinum (II) emitter for OLED applications
CN107602469B (en) Naphthalimide compound with aggregation-induced emission enhancement, solvent discoloration and self-restoring force discoloration properties and application thereof
JP6341923B2 (en) Strong fluorescent luminescent heterocyclic compound and method for producing the same
EP3172203B1 (en) Molecules presenting dual emission properties
WO2016133218A1 (en) Phospha-fluorescein compound or salt thereof, and fluorescent dye using same
JP6869524B2 (en) Method for Producing Aminobenzopyranoxanthene (ABPX) Dye Compound
Zhang et al. A series of tetraphenylethene-based benzimidazoles: syntheses, structures, aggregation-induced emission and reversible mechanochromism
Wen et al. Triphenylethylene-based fluorophores: Facile preparation and full-color emission in both solution and solid states
Petrosyan et al. Straightforward synthesis of tetraalkynylpyrazines and their photophysical properties
JP7222517B2 (en) Novel compound and its manufacturing method
Yu et al. Dipyrrolylquinoxaline difluoroborates with intense red solid-state fluorescence
JP6146214B2 (en) Benzobisthiazole compounds
EP3345973A1 (en) Rhodamine-based colorant compound and process for producing same
Bui et al. Synthesis and preliminary physical properties of new neutral tetraalkoxy-substituted nickel bis (1, 2-dithiolene) complexes
KR102468876B1 (en) Naphthobischalcogenadiazole derivatives and methods for their preparation
CN108017676A (en) A kind of polyhydroxy yellow phosphorescence complex of iridium and preparation method thereof
JP6269956B2 (en) Furylthiazole compound
JP6598573B2 (en) Novel benzoindenofluorenopyrans and process for producing the same
JP6226363B2 (en) Bis-boron dipyrromethene dye
Voloshin et al. Spiropyrans and spirooxazines 10. Synthesis of photochromic 5′-(1, 3-benzoxazol-2-yl)-substituted spiro [indoline-naphthopyrans]
CN109233325A (en) A kind of two pyrroles&#39;s fluorescent dye of asymmetry benzo fluorine boron and its preparation method
KR101397530B1 (en) Facile “one pot” route to the novel benzazulene-type dye class: asymmetric, derivatizable, 5-7-6 fused ring puckered half BODIPY design
JP6516272B2 (en) Carbon nanobelt and method of manufacturing the same
CN115746035A (en) Fluorine-boron fluorescent dye derivative and preparation method and application thereof
KR102110059B1 (en) Phenacene compound, manufacturing method of phenacene compound, and organic light emitting device

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20161122

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20161128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191004

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20191106

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210323

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210407

R150 Certificate of patent or registration of utility model

Ref document number: 6869524

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250